D DICOM Controlled Terminology Definitions (Normative)

This Annex specifies the meanings of codes defined in DICOM, either explicitly or by reference to another part of DICOM or an external reference document or standard.

DICOM Code Definitions (Coding Scheme Designator "DCM" Coding Scheme Version "01")

Table D-1. DICOM Controlled Terminology Definitions

Code Value

Code Meaning

Definition

Notes

ARCHIVE

Archive

Archive device.

AR

Autorefraction

Autorefraction device.

AS

Angioscopy

Angioscopy device

Retired

AU

Audio

Audio object.

BDUS

Ultrasound Bone Densitometry

Ultrasound Bone Densitometry (modality).

BI

Biomagnetic imaging

Biomagnetic imaging device.

BMD

Bone Mineral Densitometry

Bone Mineral Densitometry by X-Ray (modality), including dual-energy X-Ray absorptiometry (DXA) and morphometric X-Ray absorptiometry (MXA).

CAD

Computer Assisted Detection/Diagnosis

Computer Assisted Detection/Diagnosis device.

CAPTURE

Image Capture

Image Capture Device, includes video capture.

CD

Color flow Doppler

Color flow Doppler

Retired

Replaced by (US, DCM, "Ultrasound")

CF

Cinefluorography

Cinefluorography

Retired

Replaced by (RF, DCM, "Radiofluoroscopy")

COMP

Computation Server

Computation Server; includes radiotherapy planning.

CP

Culposcopy

Culposcopy

Retired

CR

Computed Radiography

Computed Radiography device.

CS

Cystoscopy

Cystoscopy

Retired

CT

Computed Tomography

Computed Tomography device.

DD

Duplex Doppler

Duplex Doppler

Retired

Replaced by (US, DCM, "Ultrasound")

DF

Digital fluoroscopy

Digital fluoroscopy

Retired

Replaced by (RF, DCM, "Radiofluoroscopy")

DG

Diaphanography

Diaphanography device.

DM

Digital microscopy

Digital microscopy

Retired

DOCD

Document Digitizer Equipment

Equipment that digitized hardcopy documents and imported them.

DS

Digital Subtraction Angiography

Digital Subtraction Angiography

Retired

Replaced by (XA, DCM, "X-Ray Angiography")

DSS

Department System Scheduler

Department System Scheduler, workflow manager; includes RIS.

DX

Digital Radiography

Digital Radiography device.

EC

Echocardiography

Echocardiography

Retired

Replaced by (US, DCM, "Ultrasound")

ECG

Electrocardiography

Electrocardiography device.

EPS

Cardiac Electrophysiology

Cardiac Electrophysiology device.

ES

Endoscopy

Endoscopy device.

F

Female

Female sex.

FA

Fluorescein angiography

Fluorescein angiography

Retired

Replaced by (OP, DCM, "Ophthalmic photography")

FC

Female changed to Male

Female sex changed to Male sex.

FILMD

Film Digitizer

Film Digitizer.

FP

Female Pseudohermaphrodite

Female Pseudohermaphrodite.

FS

Fundoscopy

Fundoscopy

Retired

GM

General Microscopy

General Microscopy device.

H

Hermaphrodite

Hermaphrodite.

HC

Hard Copy

Hard Copy.

HD

Hemodynamic Waveform

Hemodynamic Waveform acquisition device.

IO

Intra-oral Radiography

Intra-oral Radiography device.

IVUS

Intravascular Ultrasound

Intravascular Ultrasound device.

KER

Keratometry

Keratometry device.

KO

Key Object Selection

Key Object Selection object.

LEN

Lensometry

Lensometry device.

LOG

Procedure Logging

Procedure Logging device; includes cath lab logging.

LP

Laparoscopy

Laparoscopy

Retired

LS

Laser surface scan

Laser surface scan device.

M

Male

Male sex.

MA

Magnetic resonance angiography

Magnetic resonance angiography

Retired

Replaced by (MR, DCM, "Magnetic resonance")

MC

Male changed to Female

Male sex changed to Female sex.

MCD

Media Creation Device

A device that creates DICOM PS3.10 interchange media. E.g., a CD creator that is managed by the Media Creation Management Service Class.

MEDIM

Portable Media Importer Equipment

Equipment that retrieved and imported objects from interchange Media.

MG

Mammography

Mammography device.

MP

Male Pseudohermaphrodite

Male Pseudohermaphrodite.

MR

Magnetic Resonance

Magnetic Resonance device.

MS

Magnetic resonance spectroscopy

Magnetic resonance spectroscopy

Retired

Replaced by (MR, DCM, "Magnetic resonance")

NEARLINE

Nearline

Instances need to be retrieved from relatively slow media such as optical disk or tape.

NM

Nuclear Medicine

Nuclear Medicine device.

OAM

Ophthalmic Axial Measurements

Measurements of the axial length of the eye, which are done by various devices.

OCT

Optical Coherence Tomography

Modality device that uses an interferometric, non-invasive optical tomographic technique to image 2D slices and 3D volumes of tissue using visible and near visible frequencies.

OFFLINE

Offline

Instances need to be retrieved by manual intervention.

ONLINE

Online

Instances are immediately available.

OP

Ophthalmic photography

Ophthalmic photography modality.

OPM

Ophthalmic Mapping

Modality device that measures corneal topography, corneal or retinal thickness, and other similar parameters that are typically displayed as maps.

OPR

Ophthalmic Refraction

Modality device that measures the refractive characteristics of the eye.

OPT

Ophthalmic Tomography

Tomography of the eye acquired by a modality that is based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded.

OPV

Ophthalmic Visual Field

Modality device that measures visual fields and perform visual perimetry.

OT

Other Modality

Other Modality device.

PR

Presentation State

Presentation State object.

PRINT

Hard Copy Print Server

Hard Copy Print Server; includes printers with embedded DICOM print server.

PT

Positron emission tomography

Positron emission tomography (PET) device.

PX

Panoramic X-Ray

Panoramic X-Ray device.

REG

Registration

Registration.

RF

Radiofluoroscopy

Radiofluoroscopy device.

RG

Radiographic imaging

Radiographic imaging (conventional film/screen).

RT

Radiation Therapy Device

Radiation Therapy Device; includes linear accelerator, proton therapy.

RTDOSE

Radiotherapy Dose

Radiotherapy Dose.

RTIMAGE

Radiotherapy Image

Radiotherapy Imaging device; includes portal imaging.

RTPLAN

Radiotherapy Plan

Radiotherapy Plan.

RTRECORD

Radiotherapy Treatment Record

Radiotherapy Treatment Record.

RTSTRUCT

Radiotherapy Structure Set

Radiotherapy Structure Set.

SEG

Segmentation

Segmentation.

SM

Slide Microscopy

Slide Microscopy.

SMR

Stereometric Relationship

Stereometric image pairing modality.

SR

Structured Report Document

Structured Report Document.

SRF

Subjective Refraction

Subjective Refraction device.

ST

Single-photon emission computed tomography

Single-photon emission computed tomography (SPECT) device

Retired

Replaced by (NM, DCM, "Nuclear Medicine")

TG

Thermography

Thermography device.

U

Unknown Sex

Unknown Sex.

UNAVAILABLE

Unavailable

Instances cannot be retrieved.

US

Ultrasound

Ultrasound device.

VA

Visual Acuity

Visual Acuity device.

VF

Videofluorography

Videofluorography

Retired

Replaced by (RF, DCM, "Radiofluoroscopy")

VIDD

Video Tape Digitizer Equipment

Equipment that digitizes video tape and imports it.

WSD

Workstation

Workstation.

XA

X-Ray Angiography

X-Ray Angiography device.

XC

External-camera Photography

External-camera Photography device.

109001

Digital timecode (NOS)

A signal transmitted for the purpose of interchange of the current time, not specific to any source or methodology.

109002

ECG-based gating signal, processed

A signal that is generated for each detection of a heart beat.

109003

IRIG-B timecode

A signal transmitted by the Inter-Range Instrumentation Group for the purpose of synchronizing time clocks.

109004

X-Ray Fluoroscopy On Signal

A signal that indicates that X-Ray source has been activated for fluoroscopy use.

109005

X-Ray On Trigger

A signal that indicated that the X-Ray source has been activated for image recording.

109006

Differential signal

An electrical signal derived from two electrodes.

109007

His bundle electrogram

An electrophysiological recording from the HIS nerve bundle.

109008

Monopole signal

An electrical signal from one electrode relative to an indifferent potential.

109009

Pacing (electrical) stimulus, voltage

The voltage stimulus during cardiac pacing.

109010

Radio frequency ablation, power

The power injected during RF ablation procedure.

109011

Voltage measurement by basket catheter

Electrophysiological signals acquired using a multi-splined catheter each equipped with multiple electrodes.

109012

Voltage measurement by mapping catheter

Electrophysiological signals acquired using a steerable catheter.

109013

Voltage measurement, NOS

A voltage measurement not otherwise specified.

109014

35% of thermal CO

A signal point that is 35% of the peak thermal cardiac output signal.

109015

70% of thermal CO

A signal point that is 70% of the peak thermal cardiac output signal.

109016

A wave peak pressure

The peak pressure of each heart beat in the atrium caused by the atrial contraction.

109017

A wave pressure, average

The average of several A wave pressure measurements.

109018

Beat detected (accepted)

An identified cardiac beat used in the determination of a measurement.

109019

Beat detected (rejected)

An identified cardiac beat not used in the determination of a measurement.

109020

Diastolic pressure, average

The average of several diastolic pressure measurements

Retired. Replaced by (F-00E22, SRT, "Average diastolic blood pressure")

109021

Diastolic pressure nadir

The lowest pressure value excluding any undershoot artifact.

Retired. Replaced by (F-00E1F, SRT, "Minimum diastolic blood pressure")

109022

End diastole

The moment at the end of the diastolic phase of the cardiac cycle.

Retired. Replaced by (F-32011, SRT, "End diastole")

109023

End of expiration

The moment at the end of respiratory expiration.

109024

End of inspiration

The moment at the end of respiratory inspiration.

109025

Max dp/dt

The maximum positive rate of change of pressure.

109026

Max neg dp/dt

The maximum negative rate of change of pressure.

109027

Mean blood pressure

The average blood pressure value, generally over 2 or more seconds

Retired. Replaced by (F-31150, SRT, "Mean blood pressure")

109028

Peak of thermal cardiac output bolus

The peak change in blood temperature during a thermal cardiac output measurement.

109029

Start of expiration

The moment respiratory expiration begins.

109030

Start of inspiration

The moment of respiratory inspiration begins.

109031

Start of thermal cardiac output bolus

The first discernible blood temperature change following the injectate during a thermal cardiac output measurement.

109032

Systolic pressure, average

The average of several systolic blood pressure measurements.

Retired. Replaced by (F-00E14, SRT, "Average systolic blood pressure")

109033

Systolic peak pressure

The highest systolic blood pressure value excluding any overshoot artifact

Retired. Replaced by (F-00E11, SRT, "Maximum systolic blood pressure")

109034

V wave peak pressure

The peak pressure of each heart beat in the atrium caused by the filling of the atrium.

109035

V wave pressure, average

The average of several V wave pressure measurements.

109036

Valve close

The moment at which a heart valve closes.

109037

Valve open

The moment at which a heart valve opens.

109038

Ablation off

The moment when RF ablation current is turned off.

109039

Ablation on

The moment when RF ablation current is turned on.

109040

HIS bundle wave

The moment in the cardiac cycle when the HIS bundle nerves depolarize.

109041

P wave

The surface electrocardiogram of the atrial contraction.

109042

Q wave

The first negative deflection of the electrocardiogram cause by ventricular depolarization.

109043

R wave

The first positive deflection the electrocardiogram cause by ventricular depolarization.

109044

S wave

The first negative deflection after the R wave.

109045

Start of atrial contraction

The beginning of the atrial contraction.

109046

Start of atrial contraction (subsequent)

The beginning of the second atrial contraction of two consecutive beats.

109047

Stimulation at rate 1 interval

The stimulation interval during cardiac stimulation first used in a pacing train.

109048

Stimulation at rate 2 interval

The stimulation interval different from the first stimulation interval used in a pacing train.

109049

Stimulation at rate 3 interval

A stimulation interval different from and subsequent to the second interval in a pacing train.

109050

Stimulation at rate 4 interval

Describes a stimulation interval different from and subsequent to the third interval in a pacing train.

109051

T wave

The electrocardiogram deflection caused by ventricular repolarization.

109052

V wave

The peak pressure of each heart beat monitored in the atrium caused by the filling of the atrium.

109053

V wave of next beat

The second V wave measurement of two consecutive beats.

109054

Patient State

A description of the physiological condition of the patient.

109055

Protocol Stage

The exercise level during a progressive cardiac stress test.

109056

Stress Protocol

A series of physiological challenges designed to progressively increase the work of the heart.

109057

Catheterization Procedure Phase

A subpart of a cardiac catheterization procedure

Retired. Replaced by (G-72BB, SRT, "Catheterization Procedure Phase")

109058

Contrast Phase

The subpart of a cardiac catheterization procedure in which a radio-opaque contrast medium is injected into the patient.

109059

Physiological challenges

Physical changes administered to a patient in order to elicit an physiological response.

109060

Procedure Step Number

Enumeration of a subpart of a catheterization procedure.

109061

EP Procedure Phase

A subpart of en electrophysiological procedure.

109063

Pulse train definition

A means of defining a series of cardiac stimulation pulses.

109070

End of systole

Retired. Replaced by (R-FAB5B, SRT, "End systole")

109071

Indicator mean transit time

Time for a median particle to travel from point of injection to point of detection.

109072

Tau

The time constant of isovolumic pressure fall.

109073

V max myocardial

Maximum velocity of myocardial contractility.

109080

Real time acquisition

Total time for the acquisition is shorter than cardiac cycle, no gating is applied; see Cardiac Synchronization Technique (0018,9037).

109081

Prospective gating

Certain thresholds have been set for a gating window that defines the acceptance of measurement data during the acquisition; see Cardiac Synchronization Technique (0018,9037).

109082

Retrospective gating

Certain thresholds have been set for a gating window that defines the acceptance of measurement data after the acquisition; see Cardiac Synchronization Technique (0018,9037).

109083

Paced

There is a constant RR interval, which makes thresholding not required; see Cardiac Synchronization Technique (0018,9037). E.g., Pacemaker.

109091

Cardiac Stress State

Imaging after injection of tracer during increased cardiac workload or increased myocardial blood flow, achieved by either exercise or pharmacologic means.

Retired. Replaced by (F-05019, SRT, "Cardiac stress state").

109092

Reinjection State

Imaging after injection of additional tracer under resting conditions.

109093

Redistribution State

Imaging after allowing a moderate amount of time for tracer to move from its initial sites of uptake.

Example: For Thallium imaging this would correspond to imaging 2-6 hours after injection.

109094

Delayed Redistribution State

Imaging after allowing an extended amount of time for tracer to move from its initial sites of uptake.

Example: For Thallium imaging this would correspond to imaging more than 6 hours after injection.

109095

Peak stress state

Peak Cardiac stress state

Retired. Replaced by (F-05028, SRT, "Peak stress state")

109096

Recovery state

Recovery from cardiac stress

Retired. Replaced by (F-05018, SRT, "Cardiac stress Recovery state")

109101

Acquisition Equipment

Equipment that originally acquired the data stored within composite instances. E.g., a CT, MR or Ultrasound modality.

109102

Processing Equipment

Equipment that has processed composite instances to create new composite instances. E.g., a 3D Workstation.

109103

Modifying Equipment

Equipment that has modified existing composite instances (without creating new composite instances). E.g., a QA Station or Archive.

109104

De-identifying Equipment

Equipment that has modified an existing composite instance to remove patient identifying information.

109105

Frame Extracting Equipment

Equipment that has processed composite instances to create new composite instances by extracting selected frames from the original instance.

109106

Enhanced Multi-frame Conversion Equipment

Equipment that has processed composite instances to create new composite instances by converting classic single frame images to enhanced multi-frame image, or vice versa and updating other instances to maintain referential integrity.

109110

Voice

The sound of a human's speech, recorded during a procedure.

May include the patient's voice, or the voice of staff present in the room, or an operator's voice (whether for the purpose of recording a narrative accompanying a procedure or not).

109111

Operator's narrative

The voice of a device operator, recorded during a procedure.

109112

Ambient room environment

The ambient sound recorded during a procedure, which may or may not include voice and other types of sound.

109113

Doppler audio

The Doppler waveform recorded as an audible signal.

109114

Phonocardiogram

The sound of the human heart beating.

Such as might be recorded from an electronic stethoscope.

109115

Physiological audio signal

Any sound made by the human body.

May include the sound of the heart, but also sound from other organs, such as bowel sounds or bruits from vessels, or sounds of respiration. Not intended to include voice.

109116

Arterial Pulse Waveform

A digitized signal from the patient arterial system collected through pulse oximetry or other means.

109117

Respiration Waveform

A digitized signal from the patient respiratory system representing respiration.

109120

On admission to unit

The occasion on which a procedure was performed on admission to a specialist unit. E.g., intensive care.

109121

On discharge

The occasion on which a procedure was performed on discharge from hospital as an in-patient.

109122

On discharge from unit

The occasion on which a procedure was performed on discharge from a specialist unit. E.g., intensive care.

109123

Pre-intervention

The occasion on which a procedure was performed immediately prior to non-surgical intervention. E.g, percutaneous angioplasty, biopsy.

109124

Post-intervention

The occasion on which a procedure was performed immediately after to non-surgical intervention. E.g, percutaneous angioplasty, biopsy.

109125

At last appointment

The occasion on which a procedure was performed at the most recent outpatient visit.

109132

Joint position method

The active or passive joint positioning during acquisition.

109133

Physical force

A physical force applied during acquisition.

109134

Prior to voiding

Prior to voiding.

109135

Post voiding

Post voiding.

109136

Neutral musculoskeletal position

Neutral musculoskeletal position.

109200

America Kennel Club

America Kennel Club.

109201

America's Pet Registry Inc.

America's Pet Registry Inc.

109202

American Canine Association

American Canine Association.

109203

American Purebred Registry

American Purebred Registry.

109204

American Rare Breed Association

American Rare Breed Association.

109205

Animal Registry Unlimited

Animal Registry Unlimited.

109206

Animal Research Foundation

Animal Research Foundation.

109207

Canadian Border Collie Association

Canadian Border Collie Association.

109208

Canadian Kennel Club

Canadian Kennel Club.

109209

Canadian Livestock Records Association

Canadian Livestock Records Association.

109210

Canine Federation of Canada

Canine Federation of Canada.

109211

Continental Kennel Club

Continental Kennel Club.

109212

Dog Registry of America

Dog Registry of America.

109213

Federation of International Canines

Federation of International Canines.

109214

International Progressive Dog Breeders' Alliance

International Progressive Dog Breeders' Alliance.

109215

National Kennel Club

National Kennel Club.

109216

North American Purebred Dog Registry

North American Purebred Dog Registry.

109217

United All Breed Registry

United All Breed Registry.

109218

United Kennel Club

United Kennel Club.

109219

Universal Kennel Club International

Universal Kennel Club International.

109220

Working Canine Association of Canada

Working Canine Association of Canada.

109221

World Kennel Club

World Kennel Club.

109222

World Wide Kennel Club

World Wide Kennel Club.

110001

Image Processing

Image processing work item.

110002

Quality Control

Quality control work item.

110003

Computer Aided Diagnosis

Computer aided diagnosis work item.

110004

Computer Aided Detection

Computer aided detection work item.

110005

Interpretation

Interpretation work item.

110006

Transcription

Transcription work item.

110007

Report Verification

Report verification work item.

110008

Print

Print work item.

110009

No subsequent Workitems

110010

Film

Film type of output.

110011

Dictation

Dictation type of output.

110012

Transcription

Transcription type of output.

110013

Media Import

The procedure to read DICOM instances from DICOM interchange media, coerce identifying attributes into the local namespace if necessary, and make the instances available.

110020

Sheet Film Digitized

Digitization of Sheet Film.

110021

Cine Film Digitized

Digitization of Cine Film.

110022

Video Tape Digitized

Digitization of Video Tape.

110023

Paper Digitized

Digitization of pages of a paper document (Units may be specified as Pages, Documents).

110024

CD Imported

Importation of CD.

110025

DVD Imported

Importation of DVD.

110026

MOD Imported

Importation of MOD.

110027

Studies Imported

Importation of DICOM Studies.

110028

Instances Imported

Importation of DICOM Composite Instances.

110030

USB Disk Emulation

A device that connects using the USB hard drive interface. These may be USB-Sticks, portable hard drives, and other technologies.

110031

Email

Email and email attachments used as a media for data transport.

110032

CD

CD-R, CD-ROM, and CD-RW media used for data transport.

110033

DVD

DVD, DVD-RAM, and other DVD formatted media used for data transport.

110034

Compact Flash

Media that comply with the Compact Flash standard.

110035

Multi-media Card

Media that comply with the Multi-media Card standard.

110036

Secure Digital Card

Media that comply with the Secure Digital Card standard.

110037

URI

URI Identifier for network or other resource, see RFC 3968.

110038

Paper Document

Any paper or similar document.

110100

Application Activity

Audit event: Application Activity has taken place.

110101

Audit Log Used

Audit event: Audit Log has been used.

110102

Begin Transferring DICOM Instances

Audit event: Storage of DICOM Instances has begun.

110103

DICOM Instances Accessed

Audit event: DICOM Instances have been created, read, updated, or deleted -audit event.

110104

DICOM Instances Transferred

Audit event: Storage of DICOM Instances has been completed.

110105

DICOM Study Deleted

Audit event: Entire Study has been deleted.

110106

Export

Audit event: Data has been exported out of the system.

110107

Import

Audit event: Data has been imported into the system.

110108

Network Entry

Audit event: System has joined or left network.

110109

Order Record

Audit event: Order has been created, read, updated or deleted.

110110

Patient Record

Audit event: Patient Record has been created, read, updated, or deleted.

110111

Procedure Record

Audit event: Procedure Record has been created, read, updated, or deleted.

110112

Query

Audit event: Query has been made.

110113

Security Alert

Audit event: Security Alert has been raised.

110114

User Authentication

Audit event: User Authentication has been attempted.

110120

Application Start

Audit event: Application Entity has started.

110121

Application Stop

Audit event: Application Entity has stopped.

110122

Login

Audit event: User login has been attempted.

110123

Logout

Audit event: User logout has been attempted.

110124

Attach

Audit event: Node has been attached.

110125

Detach

Audit event: Node has been detached.

110126

Node Authentication

Audit event: Node Authentication has been attempted.

110127

Emergency Override Started

Audit event: Emergency Override has started.

110128

Network Configuration

Audit event: Network configuration has been changed.

110129

Security Configuration

Audit event: Security configuration has been changed.

110130

Hardware Configuration

Audit event: Hardware configuration has been changed.

110131

Software Configuration

Audit event: Software configuration has been changed.

110132

Use of Restricted Function

Audit event: A use of a restricted function has been attempted.

110133

Audit Recording Stopped

Audit event: Audit recording has been stopped.

110134

Audit Recording Started

Audit event: Audit recording has been started.

110135

Object Security Attributes Changed

Audit event: Security attributes of an object have been changed.

110136

Security Roles Changed

Audit event: Security roles have been changed.

110137

User security Attributes Changed

Audit event: Security attributes of a user have been changed.

110138

Emergency Override Stopped

Audit event: Emergency Override has Stopped.

110139

Remote Service Operation Started

Audit event: Remote Service Operation has Begun.

110140

Remote Service Operation Stopped

Audit event: Remote Service Operation has Stopped.

110141

Local Service Operation Started

Audit event: Local Service Operation has Begun.

110142

Local Service Operation Stopped

Audit event: Local Service Operation Stopped.

110150

Application

Audit participant role ID of software application.

110151

Application Launcher

Audit participant role ID of software application launcher, i.e., the entity that started or stopped an application.

110152

Destination Role ID

Audit participant role ID of the receiver of data.

110153

Source Role ID

Audit participant role ID of the sender of data.

110154

Destination Media

Audit participant role ID of media receiving data during an export.

110155

Source Media

Audit participant role ID of media providing data during an import.

110180

Study Instance UID

ParticipantObjectID type: Study Instance UID.

110181

SOP Class UID

ParticipantObjectID type: SOP Class UID.

110182

Node ID

ID of a node that is a participant object of an audit message.

110190

Issuer of Identifier

System, organization, agency, or department that has assigned an instance identifier (such as placer or filler number, patient or provider identifier, etc.).

110500

Doctor canceled procedure

Procedure order canceled by requesting physician or other authorized physician.

110501

Equipment failure

Equipment failure prevented completion of procedure.

110502

Incorrect procedure ordered

Procedure discontinued due to incorrect procedure being ordered.

110503

Patient allergic to media/contrast

Procedure discontinued due to patient allergy to media/contrast (reported or reaction).

110504

Patient died

Procedure discontinued due to death of Patient.

110505

Patient refused to continue procedure

Procedure discontinued due to patient refusal to continue procedure.

110506

Patient taken for treatment or surgery

Procedure discontinued due to patient being taken for treatment or surgery.

110507

Patient did not arrive

Patient did not arrive for procedure.

110508

Patient pregnant

Procedure discontinued due to patient pregnancy (reported or determined).

110509

Change of procedure for correct charging

Procedure discontinued to restart with new procedure code for correct charging.

110510

Duplicate order

Procedure discontinued due to duplicate orders received for same procedure.

110511

Nursing unit cancel

Procedure order canceled by nursing unit.

110512

Incorrect side ordered

Procedure discontinued due to incorrect side (laterality) being ordered.

110513

Discontinued for unspecified reason

Procedure discontinued for unspecified reason.

110514

Incorrect worklist entry selected

Procedure discontinued due to incorrect patient or procedure step selected from modality worklist.

110515

Patient condition prevented continuing

Patient condition prevented continuation of procedure.

110516

Equipment change

Procedure step is discontinued to change to other equipment or modality.

110518

Patient Movement

A movement of the patient affecting test quality.

110519

Operator Error

An error of the operator affecting test quality.

110521

Objects incorrectly formatted

One or more of the objects is malformed.

110522

Object Types not supported

Receiving System is unable to accept the object type.

110523

Object Set incomplete

One or more objects associated with the object set is missing.

110524

Media Failure

The contents of the Media could not be accessed properly.

110526

Resource pre-empted

Procedure discontinued due to necessary equipment, staff or other resource becoming (temporarily) unavailable to the procedure.

110527

Resource inadequate

Procedure discontinued due to necessary equipment, staff or other resource being inadequate to complete the procedure.

110528

Discontinued Procedure Step rescheduled

A new Procedure Step has been scheduled to replace the Discontinued Procedure Step.

110529

Discontinued Procedure Step rescheduling recommended

It is recommended that a new Procedure Step be scheduled to replace the Discontinued Procedure Step.

110700

Ventral Diencephalon

Ventral structures of the diencephalon that cannot readily be distinguished on MR imaging, including the hypothalamus, mammillary body, subthalamic nuclei, substantia nigra, red nucleus, lateral geniculate nucleus, medial geniculate nucleus, zona incerta, cerebral peduncle, lenticular fasciculus, medial lemniscus, and optic tract.

See http://neuromorphometrics.org:8080/Seg/html/segmentation/ventral%20diencephalon.html.

110701

White Matter T1 Hypointensity

Area(s) of reduced intensity on T1 weighted images relative to the surrounding white matter.

These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T2 hyperintensity, but the concept is specifically confined to the MR appearance on T1 weighted images.

110702

White Matter T2 Hyperintensity

Area(s) of increased intensity on T2 weighted images relative to the surrounding white matter.

These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T1 hypointensity, but the concept is specifically confined to the MR appearance on T2 weighted images.

110800

Spin Tagging Perfusion MR Signal Intensity

Signal intensity of a Spin tagging Perfusion MR image. Spin tagging is a technique for the measurement of blood perfusion, based on magnetically labeled arterial blood water as an endogenous tracer.

110801

Contrast Agent Angio MR Signal Intensity

Signal intensity of a Contrast Agent Angio MR image.

110802

Time Of Flight Angio MR Signal Intensity

Signal intensity of a Time-of-flight (TOF) MR image. Time-of-flight (TOF) is based on the phenomenon of flow-related enhancement of spins entering into an imaging slice. As a result of being unsaturated, these spins give more signal that surrounding stationary spins.

110803

Proton Density Weighted MR Signal Intensity

Signal intensity of a Proton Density Weighted MR image. All MR images have intensity proportional to proton density. Images with very little T1 or T2 weighting are called 'PD-weighted'.

110804

T1 Weighted MR Signal Intensity

Signal intensity of T1 Weighted MR image. A T1 Weighted MR image is created typically by using short TE and TR times.

110805

T2 Weighted MR Signal Intensity

Signal intensity of a T2 Weighted MR image. T2 Weighted image contrast state is approached by imaging with a TR long compared to tissue T1 (to reduce T1 contribution to image contrast) and a TE between the longest and shortest tissue T2s of interest.

110806

T2* Weighted MR Signal Intensity

Signal intensity of a T2* Weighted MR image. The T2* phenomenon results from molecular interactions (spin spin relaxation) and local magnetic field non-uniformities, which cause the protons to precess at slightly different frequencies.

110807

Field Map MR Signal Intensity

Signal intensity of a Field Map MR image. A Field Map MR image provides a direct measure of the B 0 inhomogeneity at each point in the image.

110808

Fractional Anisotropy

Coefficient reflecting the fractional anisotropy of the tissues, derived from a diffusion weighted MR image. Fractional anisotropy is proportional to the square root of the variance of the Eigen values divided by the square root of the sum of the squares of the Eigen values.

110809

Relative Anisotropy

Coefficient reflecting the relative anisotropy of the tissues, derived from a diffusion weighted MR image.

110810

Volumetric Diffusion Dxx Component

Dxx Component of the diffusion tensor, quantifying the molecular mobility along the X axis.

110811

Volumetric Diffusion Dxy Component

Dxy Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Y directions.

110812

Volumetric Diffusion Dxz Component

Dxz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Z directions.

110813

Volumetric Diffusion Dyy Component

Dyy Component of the diffusion tensor, quantifying the molecular mobility along the Y axis.

110814

Volumetric Diffusion Dyz Component

Dyz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the Y and Z directions.

110815

Volumetric Diffusion Dzz Component

Dzz Component of the diffusion tensor, quantifying the molecular mobility along the Z axis.

110816

T1 Weighted Dynamic Contrast Enhanced MR Signal Intensity

Signal intensity of a T1 Weighted Dynamic Contrast Enhanced MR image. A T1 Weighted Dynamic Contrast Enhanced MR image reflects the dynamics of diffusion of the exogenous contrast media from the blood pool into the extra vascular extracellular space (EES) of the brain at a rate determined by the blood flow to the tissue, the permeability of the Brain Blood Barrier (BBB), and the surface area of the perfusing vessels.

110817

T2 Weighted Dynamic Contrast Enhanced MR Signal Intensity

Signal intensity of a T2 Weighted Dynamic Contrast Enhanced MR image. A T2 Weighted Dynamic Contrast Enhanced MR image reflects the T2 of tissue decrease as the Gd contrast agent bolus passes through the brain.

110818

T2* Weighted Dynamic Contrast Enhanced MR Signal Intensity

Signal intensity of a T2* Weighted Dynamic Contrast Enhanced MR image. A T2* Weighted Dynamic Contrast Enhanced MR image reflects the T2* of tissue decrease as the Gd contrast agent bolus passes through the brain.

110819

Blood Oxygenation Level

Signal intensity of a Blood Oxygenation Level image. BOLD imaging is sensitive to blood oxygenation (but also to cerebral blood flow and volume). This modality is essentially used for detecting brain activation (functional MR).

110820

Nuclear Medicine Projection Activity

Accumulated decay event counts in a nuclear medicine projection image.

110821

Nuclear Medicine Tomographic Activity

Accumulated decay event counts in a Nuclear Medicine Tomographic image (including PET).

110822

Spatial Displacement X Component

Spatial Displacement along axis X of a non linear deformable spatial registration image. The X axis is defined in reference to the patient's orientation, and is increasing to the left hand side of the patient.

110823

Spatial Displacement Y Component

Spatial Displacement along axis Y of a non linear deformable spatial registration image. The Y axis is defined in reference to the patient's orientation, and is increasing to the posterior side of the patient.

110824

Spatial Displacement Z Component

Spatial Displacement along axis Z of a Non linear deformable spatial registration image. The Z axis is defined in reference to the patient's orientation, and is increasing toward the head of the patient.

110825

Hemodynamic Resistance

Measured resistance to the flow of blood. E.g., through the vasculature or through a heart value.

110826

Indexed Hemodynamic Resistance

Measured resistance to the flow of blood. E.g., through the vasculature or through a heart value, normalized to a particular indexed scale.

110827

Tissue Velocity

Velocity of tissue based on Doppler measurements.

110828

Flow Velocity

Velocity of blood flow based on Doppler measurements.

110829

Flow Variance

Statistical variance of blood velocity relative to mean.

110830

Elasticity

Scalar value related to the elastic properties of the tissue.

110831

Perfusion

Scalar value related to the volume of blood perfusing into tissue.

110832

Speed of sound

Speed of sound in tissue.

110833

Ultrasound Attenuation

Reduction in strength of ultrasound signal as the wave.

110834

RGB R Component

Red component of a true color image (RGB).

110835

RGB G Component

Green component of a true color image (RGB).

110836

RGB B Component

Blue component of a true color image (RGB).

110837

YBR FULL Y Component

Y (Luminance) component of a YBR FULL image, as defined in JPEG 2000.

110838

YBR FULL CB Component

CB (Blue chrominance) component of a YBR FULL image, as defined in JPEG 2000.

110839

YBR FULL CR Component

CR (Red chrominance) component of a YBR FULL image, as defined in JPEG 2000.

110840

YBR PARTIAL Y Component

Y (Luminance) component of a YBR PARTIAL image, as defined in JPEG 2000.

110841

YBR PARTIAL CB Component

CB (Blue chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000.

110842

YBR PARTIAL CR Component

CR (Red chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000.

110843

YBR ICT Y Component

Y (Luminance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000.

110844

YBR ICT CB Component

CB (Blue chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000.

110845

YBR ICT CR Component

CR (Red chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000.

110846

YBR RCT Y Component

Y (Luminance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000.

110847

YBR RCT CB Component

CB (Blue chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000.

110848

YBR RCT CR Component

CR (Red chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000.

110849

Echogenicity

The ability of a material to create an ultrasound return echo.

110850

X-Ray Attenuation

Decrease in the number of photons in an X-Ray beam due to interactions with the atoms of a material substance. Attenuation is due primarily to two processes, absorption and scattering.

110851

X-Ray Attenuation Coefficient

Coefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms.

110852

MR signal intensity

Signal intensity of an MR image, not otherwise specified.

110853

Binary Segmentation

Binary value denoting that the segmented property is present.

110854

Fractional Probabilistic Segmentation

Probability, defined as a percentage, that the segmented property occupies the spatial area defined by the voxel.

110855

Fractional Occupancy Segmentation

Percentage of the voxel area occupied by the segmented property.

110856

Linear Displacement

Spatial dimension, denoting a linear displacement.

110857

Photon Energy

Dimension denoting the energy (frequency or wavelength) of photons.

110858

Time

Dimension used to sequence events, to compare the duration of events and the intervals between events.

110859

Angle

Spatial dimension, denoting an angle.

110860

Left-Right Axis

A spatial dimension axis running along a line between the patient's left and right side.

110861

Head-Foot Axis

A spatial dimension axis running along a line between the patient's head and foot.

110862

Anterior-Posterior Axis

A spatial dimension axis running along a line between the patient's anterior and posterior sides.

110863

Apex-Base Axis

A spatial dimension axis running along a line between the apex and base of an organ, object, or chamber.

110864

Anterior-Inferior Axis

A spatial dimension axis running along a line between the anterior and inferior sides of an organ, object, or chamber.

110865

Septum-Wall Axis

A spatial dimension axis running along a line between the septum and wall of a chamber.

110866

Right To Left

Orientation of a spatial dimension where increasing values run from the right to the left side of the patient.

110867

Left To Right

Orientation of a spatial dimension where increasing values run from the left to the right side of the patient.

110868

Head To Foot

Orientation of a spatial dimension where increasing values run from the head to the foot of the patient.

110869

Foot To Head

Orientation of a spatial dimension where increasing values run from the foot to the head of the patient.

110870

Anterior To Posterior

Orientation of a spatial dimension where increasing values run from the anterior to the posterior side of the patient.

110871

Posterior To Anterior

Orientation of a spatial dimension where increasing values run from the posterior to the anterior side of the patient.

110872

Apex To Base

Orientation of a spatial dimension where increasing values run from the apex to the base.

110873

Base To Apex

Orientation of a spatial dimension where increasing values run from the base to the apex.

110874

Anterior To Inferior

Orientation of a spatial dimension where increasing values run from the anterior to the inferior.

110875

Inferior To Anterior

Orientation of a spatial dimension where increasing values run from the inferior to the anterior.

110876

Septum To Wall

Orientation of a spatial dimension where increasing values run from the septum of a chamber to the opposite wall.

110877

Wall To Septum

Orientation of a spatial dimension where increasing values run from the opposite wall to the septum of a chamber.

110901

Image Position (Patient) X

The x coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system.

110902

Image Position (Patient) Y

The y coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system.

110903

Image Position (Patient) Z

The z coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system.

110904

Image Orientation (Patient) Row X

The x value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system.

110905

Image Orientation (Patient) Row Y

The y value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system.

110906

Image Orientation (Patient) Row Z

The z value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system.

110907

Image Orientation (Patient) Column X

The x value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system.

110908

Image Orientation (Patient) Column Y

The y value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system.

110909

Image Orientation (Patient) Column Z

The z value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system.

110910

Pixel Data Rows

Number of rows in the pixel data of the image.

110911

Pixel Data Columns

Number of columns in the pixel data of the image.

111001

Algorithm Name

The name assigned by a manufacturer to a specific software algorithm.

111002

Algorithm Parameters

The input parameters used by a manufacturer to configure the behavior of a specific software algorithm.

111003

Algorithm Version

The software version identifier assigned by a manufacturer to a specific software algorithm.

111004

Analysis Performed

The type of correlation applied to detection results. E.g., temporal, spatial.

111005

Assessment Category

Assignment of intermediate or overall interpretation results to a general category.

111006

Breast composition

Assessment of annotating tissues in breast; generally including fatty, mixed or dense

Retired. Replaced by (F-01710, SRT, "Breast composition").

111007

Breast Outline including Pectoral Muscle Tissue

Purpose of reference for an SCOORD content item that is an outline of the breast that includes the pectoral muscle tissue

Purpose of Reference for content item of value type COMPOSITE or SCOORD

111008

Calcification Distribution

The type of distribution associated with detected calcifications.

111009

Calcification Type

Identification of the morphology of detected calcifications.

111010

Center

Purpose of reference for an SCOORD content item that identifies the central point of a finding or feature

Purpose of Reference for content item of value type COMPOSITE or SCOORD

111011

Certainty of Feature

The likelihood that the feature analyzed is in fact the type of feature identified.

111012

Certainty of Finding

The likelihood that the finding detected is in fact the type of finding identified.

111013

Certainty of Impression

The certainty that a device places on an impression, where 0 equals no certainty and 100 equals certainty.

111014

Clockface or region

A location identifier based on clockface numbering or anatomic subregion.

111015

Composite Feature

An item that is an inferred correlation relating two or more individual findings or features.

111016

Composite type

The inferred relationship between the findings or features making up a composite feature.

111017

CAD Processing and Findings Summary

General assessment of whether or not CAD processing was successful, and whether any findings resulted.

111018

Content Date

The date the data creation started.

111019

Content Time

The time the data creation started.

111020

Depth

A location identifier based on a feature's inferred distance from the surface of the associated anatomy.

111021

Description of Change

A textual description of the change that occurred over time in a qualitative characteristic of a feature.

111022

Detection Performed

The type of finding sought after by a specific algorithm applied to one image.

111023

Differential Diagnosis/Impression

A general change that occurred within an imaged area between a prior imaging procedure and the current imaging procedure.

111024

Failed Analyses

A group of analysis algorithms that were attempted, but failed.

111025

Failed Detections

A group of detection algorithms that were attempted, but failed.

111026

Horizontal Pixel Spacing

For projection radiography, the horizontal physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the horizontal physical distance in the patient between the center of each pixel.

111027

Image Laterality

Laterality of (possibly paired) body part contained in an image.

111028

Image Library

A container that references all image data used as evidence to produce a report.

111029

Image Quality Rating

A numeric value in the range 0 to 100, inclusive, where 0 is worst quality and 100 is best quality.

111030

Image Region

Purpose of reference for an SCOORD content item that identifies a specific region of interest within an image

Purpose of Reference for content item of value type COMPOSITE or SCOORD

111031

Image View

The projection of the anatomic region of interest on an image receptor.

111032

Image View Modifier

Modifier for Image View.

111033

Impression Description

Free-form text describing the overall or an individual impression.

111034

Individual Impression/Recommendation

A container for a group of related results from interpretation of one or more images and associated clinical information.

111035

Lesion Density

The X-Ray attenuation of a lesion relative to the expected attenuation of an equal volume of fibroglandular breast tissue.

111036

Mammography CAD Report

A structured report containing the results of computer-aided detection or diagnosis applied to breast imaging and associated clinical information.

111037

Margins

The characteristic of the boundary, edges or border of a detected lesion.

111038

Number of calcifications

The quantity of calcifications detected within an identified group or cluster.

111039

Object type

A non-lesion object identified within one or more images.

111040

Original Source

Purpose of reference for a COMPOSITE content item that identifies it as the original source of evidence for another content item in the report

Purpose of Reference for content item of value type COMPOSITE or SCOORD

111041

Outline

Purpose of reference for an SCOORD content item that identifies the outline or bounding region of a finding or feature

Purpose of Reference for content item of value type COMPOSITE or SCOORD

111042

Pathology

The inferred type of disease associated with an identified feature.

111043

Patient Orientation Column

The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive column axis (top to bottom).

111044

Patient Orientation Row

The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive row axis (left to right).

111045

Pectoral Muscle Outline

Purpose of reference for an SCOORD content item that is an outline of the pectoral muscle tissue only

Purpose of Reference for content item of value type COMPOSITE or SCOORD

111046

Percent Fibroglandular Tissue

Percent of breast area that is mammographically dense, excluding pectoralis muscle.

111047

Probability of cancer

The likelihood that an identified finding or feature is cancerous.

111048

Quadrant location

A location identifier based on the division of an area into four regions.

111049

Qualitative Difference

A qualitative characteristic of a feature that has changed over time.

111050

Quality Assessment

The effect of the quality of an image on its usability.

111051

Quality Control Standard

The quality control standard used to make a quality assessment.

111052

Quality Finding

A specific quality related deficiency detected within an image.

111053

Recommended Follow-up

Recommended type of follow-up to an imaging procedure, based on interpreted results.

111054

Recommended Follow-up Date

Recommended follow-up date to an imaging procedure, based on interpreted results.

111055

Recommended Follow-up Interval

Recommended follow-up interval to an imaging procedure, based on interpreted results.

111056

Rendering Intent

The recommendation of the producer of a content item regarding presentation of the content item by recipients of the report.

111057

Scope of Feature

An indication of how widespread the detection of a feature is within the analyzed image data set.

111058

Selected Region Description

A textual description of the contents of a selected region identified within an image.

111059

Single Image Finding

An item that was detected on one image.

111060

Study Date

Date on which the acquisition of the study information was started.

111061

Study Time

Time at which the acquisition of the study information was started.

111062

Successful Analyses

A group of analysis algorithms that were attempted and completed successfully.

111063

Successful Detections

A group of detection algorithms that were attempted and completed successfully.

111064

Summary of Detections

An overall indication of whether the CAD detection algorithms applied were completed successfully.

111065

Summary of Analyses

An overall indication of whether the CAD analysis algorithms applied were completed successfully.

111066

Vertical Pixel Spacing

For projection radiography, the vertical physical distance measured at the front plane of an Image Receptor housing between the center of each pixel. For tomographic images, the vertical physical distance in the patient between the center of each pixel.

111069

Crosstable

111071

CAD Operating Point

One of a number of discrete points on the Receiver-Operator Characteristics (ROC) curve that reflects the expected sensitivity and specificity of a CAD algorithm, where zero indicates the highest specificity, lowest sensitivity operating point. The value should not exceed the Maximum CAD Operating Point.

111072

Maximum CAD Operating Point

The maximum value of CAD Operating Point for the specific CAD algorithm used.

111081

CAD Operating Point Description

The intended interpretation of a CAD Operating Point.

111086

False Markers per Image

The number of false CAD markers per image. Correlates to inverse of Image Specificity.

111087

False Markers per Case

The number of false markers per collection of images that are CAD processed as a group. Correlates to inverse of Case Specificity.

111088

Case Sensitivity

The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in at least one view.

111089

Lesion Sensitivity

The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in each view.

111090

Case Specificity

The percentage of cases (collections of images CAD processed as a group) without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Case.

111091

Image Specificity

The percentage of images without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Image.

111092

Recommended CAD Operating Point

The CAD operating point that is recommended for initial display by the creator of the structured report.

111093

CAD Operating Point Table

A list of CAD operating points including their corresponding characteristics.

111099

Selected region

A specific area of interest noted within an image.

111100

Breast geometry

The surface shape of all or a portion of breast related anatomy.

111101

Image Quality

Image quality incorporates the following clinical image evaluation parameters: assessment of positioning, compression, artifacts, exposure, contrast, sharpness, and labeling.

111102

Non-lesion

A finding or feature that is identified as a non-anatomic foreign object.

111103

Density

A space-occupying lesion identified in a single image or projection

Retired. Replaced by (F-01796, SRT, "Mammography breast density").

111104

Individual Calcification

A single identified calcification

Retired. Replaced by (F-01776, SRT, "Individual Calcification").

111105

Calcification Cluster

Multiple calcifications identified as occupying a small area of tissue (less than 2 cc)

Retired. Replaced by (F-01775, SRT, "Calcification Cluster").

111111

Cooper's ligament changes

Straightening or thickening of Cooper's ligaments.

111112

Mass in the skin

An abnormality noted at imaging within the dermis of the breast.

111113

Mass on the skin

An abnormality noted at imaging on the epidermis of the breast.

111120

Post Procedure Mammograms for Marker Placement

An assessment category to indicate that images have been acquired to assess marker placement following a breast interventional procedure.

111121

Follow-up post biopsy as directed by clinician

An indication that the patient should seek post procedural follow-up directives from a clinical health care provider.

111122

Known biopsy proven malignancy - take appropriate action

A recommendation on a patient with known cancer to take steps appropriate to the diagnosis.

111123

Marker placement

Positioning of a radiopaque marker.

111124

Personal history of breast cancer with mastectomy

Patient has previous diagnosis of breast cancer resulting in mastectomy.

111125

Known biopsy proven malignancy

Patient has had biopsy containing proven malignancy.

111126

Image detected mass

Patient has a finding of mass reported on a prior imaging exam.

111127

Targeted

A breast imaging procedure performed on a specific area of the breast.

111128

Survey

A breast imaging procedure performed on the entire breast.

111129

Clustered microcysts

A cluster of tiny anechoic foci each smaller than 2-3 mm in diameter with thin (less than 0.5 mm) intervening septations and no discrete solid components.

111130

Complicated cyst

A fluid filled mass most commonly characterized by homogeneous low-level internal echoes on ultrasound.

111135

Additional projections

Views not inclusive of MLO and CC (BI-RADS®).

111136

Spot magnification view(s)

A spot or coned down compression of the breast providing a reduction in the thickness and a magnification of the localized area of interest and improved separation of breast tissue.

111137

Ultrasound

Retired. Replaced by (P5-B0099, SRT, "Ultrasound procedure").

111138

Old films for comparison

Obtain previous mammography studies to compare to present study.

111139

Ductography

A medical procedure used for the sampling of mammary duct tissue

Retired. Replaced by (P5-40060, SRT, "Mammary ductogram").

111140

Normal interval follow-up

Follow up study at 12 months for women ≥ 40 years of age having a prior negative study and no mitigating risk factors for breast cancer.

111141

Any decision to biopsy should be based on clinical assessment

Any decision to perform tissue acquisition should be based on clinical assessment.

111142

Follow-up at short interval (1-11 months)

Follow-up at short interval (1-11 months).

111143

Biopsy should be considered

Tissue acquisition should be considered.

111144

Needle localization and biopsy

Breast tissue acquisition following the identification of an area of concern with the placement of a needle or needle-wire assembly.

111145

Histology using core biopsy

Pathologic analysis of breast tissue and lesions using core tissue samples.

111146

Suggestive of malignancy - take appropriate action

Lesions that do not have the characteristic morphologies of breast cancer but have a definite probability of being malignant. There is a sufficient concern to urge a biopsy.

111147

Cytologic analysis

Cellular analysis of specimen.

111148

Biopsy should be strongly considered

Tissue acquisition should be strongly considered.

111149

Highly suggestive of malignancy - take appropriate action

Lesions have a high probability of being cancer, which require additional action.

111150

Presentation Required: Rendering device is expected to present

The producer of a report intends for a recipient of the report to present or display the associated content item.

111151

Presentation Optional: Rendering device may present

The producer of a report considers the presentation or display of the associated content item by a recipient to be optional.

111152

Not for Presentation: Rendering device expected not to present

The producer of a report intends for a recipient of the report NOT to present or display the associated content item.

111153

Target content items are related temporally

The associated content items are identified as being the same finding or feature at different points in time.

111154

Target content items are related spatially

The associated content items are identified as being the same finding or feature on different projections taken at the same point in time.

111155

Target content items are related contra-laterally

The associated content items are identified as being related side-to-side.

111156

Feature detected on the only image

There is one image in the interpreted data set.

111157

Feature detected on only one of the images

There is more than one image of the same modality in the interpreted data set.

111158

Feature detected on multiple images

There is more than one image of the same modality in the interpreted data set.

111159

Feature detected on images from multiple modalities

The interpreted data set contains images from multiple modalities.

111168

Scar tissue

The fibrous tissue replacing normal tissues destroyed by disease or injury

Retired. Replaced by (M-78060, SRT, "Scar tissue").

111170

J Wire

A medical appliance used for localization of non palpable breast lesions to insure that the proper area is removed in a surgical biopsy

Retired. Replaced by (A-1016B, SRT, "J Wire").

111171

Pacemaker

A medical appliance used for regulating cardiac rhythms

Retired. Replaced by (A-11101, SRT, "Cardiac Pacemaker").

111172

Paddle

A compression device used for obtaining mammographic images

Retired. Replaced by (A-10042, SRT, "Compression paddle").

111173

Collimator

A device used for restricting an X-Ray beam

Retired. Replaced by (A-10044, SRT, "Collimator").

111174

ID Plate

An area designated on a radiographic film for facility and patient ID information

Retired. Replaced by (A-16016, SRT, "ID Plate").

111175

Other Marker

Site specific markers.

111176

Unspecified

The value of the concept is not specified

This term may not be used in Context Group Extensions; see Section 7.2.3

111177

View and Laterality Marker is missing

Image quality deficiency according to MQSA.

111178

View and Laterality Marker does not have both view and laterality

Image quality deficiency according to MQCM.

111179

View and Laterality Marker does not have approved codes

Image quality deficiency according to MQCM.

111180

View and Laterality Marker is not near the axilla

Image quality deficiency according to MQCM.

111181

View and Laterality Marker overlaps breast tissue

Image quality deficiency according to MQCM.

111182

View and Laterality Marker is partially obscured

Image quality deficiency according to MQCM.

111183

View and Laterality Marker is incorrect

Image quality deficiency.

111184

View and Laterality Marker is off image

Image quality deficiency.

111185

Flash is not near edge of film

Image quality deficiency according to MQCM.

111186

Flash is illegible, does not fit, or is lopsided

Image quality deficiency according to MQSA.

111187

Flash doesn't include patient name and additional patient id

Image quality deficiency according to MQCM.

111188

Flash doesn't include date of examination

Image quality deficiency according to MQCM.

111189

Flash doesn't include facility name and location

Image quality deficiency according to MQSA.

111190

Flash doesn't include technologist identification

Image quality deficiency according to MQCM.

111191

Flash doesn't include cassette/screen/detector identification

Image quality deficiency according to MQCM.

111192

Flash doesn't include mammography unit identification

Image quality deficiency according to MQCM.

111193

Date sticker is missing

Image quality deficiency according to MQCM.

111194

Technical factors missing

Image quality deficiency according to MQCM.

111195

Collimation too close to breast

Image quality deficiency according to MQCM.

111196

Inadequate compression

Image quality deficiency according to MQCM.

111197

MLO Insufficient pectoral muscle

Image quality deficiency according to MQCM.

111198

MLO No fat is visualized posterior to fibroglandular tissues

Image quality deficiency according to MQCM.

111199

MLO Poor separation of deep and superficial breast tissues

Image quality deficiency according to MQCM.

111200

MLO Evidence of motion blur

Image quality deficiency according to MQCM.

111201

MLO Inframammary fold is not open

Image quality deficiency according to MQCM.

111202

CC Not all medial tissue visualized

Image quality deficiency according to MQCM.

111203

CC Nipple not centered on image

Image quality deficiency according to MQCM.

111204

CC Posterior nipple line does not measure within 1 cm of MLO

Image quality deficiency according to MQCM.

111205

Nipple not in profile

Image quality deficiency.

111206

Insufficient implant displacement incorrect

Image quality deficiency according to MQCM.

111207

Image artifact(s)

Signals that do not faithfully reproduce actual anatomic structures because of distortion or of addition or deletion of information.

111208

Grid artifact(s)

Feature(s) arising from the acquisition unit's anti-scatter grid mechanism. For two-dimensional systems, such features include those of mechanically damaged or incorrectly positioned grids. For moving or Bucky grids, artifacts may result from intentional grid motion that is inadequate in duration or velocity uniformity.

111209

Positioning

Inadequate arrangement of the anatomy of interest with respect to the X-Ray field and image detector sensitive area. Examples: 1) positioning is "cutoff" when the projection of anatomy of interest falls outside the sensitive area of the detector; 2) "cone cut", in which the X-Ray field does not adequately cover the anatomy of interest; 3) detector's sensitive surface is too small to cover the projection of the anatomy of interest; 4) improper angular orientation or "rotation" of anatomy of interest with respect to the X-Ray source, or detector; 5) projection of other anatomy or clothing over the anatomy of interest in the image.

111210

Motion blur

Unacceptable image blur resulting from motion of the anatomy of interest during exposure or the inadequately compensated motion of X-Ray source with respect to the image detector during exposure.

111211

Under exposed

Inadequate number of quanta reached the detector during exposure. Reasons for under exposed images include low kVp, low mAs product, excess Source Image Distance. Under exposed images have inadequate signal and higher noise in the areas of interest.

111212

Over exposed

An excess number of quanta reached the detector during exposure. Reasons for over exposed images include high kVp, high mAs product, short Source Image Distance. Over exposed images have high signal and lower noise in the areas of interest. Over exposed area may demonstrate lack of contrast from over saturation of the detector.

111213

No image

No evidence of a patient exposure.

111214

Detector artifact(s)

Superposed features or flaws of the detector.

111215

Artifact(s) other than grid or detector artifact

Features or discontinuities arising from causes other than the anti-scatter grid and image detector.

111216

Mechanical failure

Failure of the device to operate according to mechanical design specifications.

111217

Electrical failure

Failure of a device to operate according to electrical design specifications.

111218

Software failure

Attributable to software used in generation or handling of image.

111219

Inappropriate image processing

Images processed inappropriately, not following appropriate protocol.

111220

Other failure

Failure that is not mechanical or electrical or otherwise described.

111221

Unknown failure

Unidentified or unknown cause of failure.

111222

Succeeded

The attempted process was completely successful.

111223

Partially Succeeded

The attempted process succeeded in some ways, but failed in others.

111224

Failed

The attempted process completely failed.

111225

Not Attempted

No process was performed.

111233

Individual Impression / Recommendation Analysis

Analysis of a related group of findings or features detected during image data inspection, to produce a summary impression and/or recommendation.

111234

Overall Impression / Recommendation Analysis

Analysis of all groups of findings or features, to produce a single impression and/or recommendation.

111235

Unusable - Quality renders image unusable

The usability of an image for diagnostic interpretation or CAD, based on a quality control standard.

111236

Usable - Does not meet the quality control standard

The usability of an image for diagnostic interpretation or CAD, based on a quality control standard.

111237

Usable - Meets the quality control standard

The usability of an image for diagnostic interpretation or CAD, based on a quality control standard.

111238

Mammography Quality Control Manual 1999, ACR

An image quality control standard specified by the American College of Radiology.

111239

Title 21 CFR Section 900, Subpart B

An image quality control standard in the US Code of Federal Regulations.

111240

Institutionally defined quality control standard

An image quality control standard specified or adopted by the institution responsible for the document.

111241

All algorithms succeeded; without findings

No findings resulted upon successful completion of all attempted computer-aided detection and/or analysis.

111242

All algorithms succeeded; with findings

One or more findings resulted upon successful completion of all attempted computer-aided detection and/or analysis.

111243

Not all algorithms succeeded; without findings

No findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process.

111244

Not all algorithms succeeded; with findings

One or more findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process.

111245

No algorithms succeeded; without findings

All of the attempted computer-aided detection and/or analysis failed, so there could be no findings.

111248

Adenolipoma

A benign tumor having glandular characteristics but composed of fat, with the presence of normal mammary ducts

Retired. Replaced by (M-83240, SRT, "Adenolipoma").

111249

Ductal hyperplasia

Retired. Replaced by (M-72170, SRT, "Ductal hyperplasia, Usual").

111250

Adenomyoepithelioma

Neoplasms composed of myoepithelial cells

Retired. Replaced by (M-89830, SRT, "Adenomyoepithelioma").

111251

Normal axillary node

Axillary node that is normal in appearance with no associated pathology.

111252

Axillary node with calcifications

Axillary node containing calcifications.

111253

Axillary node hyperplasia

Excessive proliferation of normal tissue arrangement of the axillary node.

111254

Asynchronous involution

Retired. Replaced by (F-8A063, SRT, "Asynchronous involution of breast").

111255

Benign cyst with blood

Cyst with benign morphology containing blood.

111256

Benign Calcifications

Calcifications having typically benign morphology. They are not of intermediate or high probability of concern for malignancy.

111257

Intracystic papilloma

Growing within a cystic adenoma, filling the cavity with a mass of branching epithelial processes

Retired. Replaced by (M-85040, SRT, "Intracystic papilloma").

111258

Ductal adenoma

Adenoma located in mammary duct, present as discrete sclerotic nodules, solitary or multiple.

111259

Diabetic fibrous mastopathy

The occurrence of fibrous tumor-forming stromal proliferation in patients with diabetes mellitus.

111260

Extra abdominal desmoid

A deep seated firm tumor frequently occurring on the chest consisting of collagenous tissue that infiltrates surround muscle; frequently recurs but does not metastasize

Retired. Replaced by (M-88211, SRT, "Extra abdominal desmoid").

111262

Epidermal inclusion cyst

A cyst formed of a mass of epithelial cells, as a result of trauma has been pushed beneath the epidermis. The cyst is lined with squamous epithelium and contains concentric layers or keratin

Retired. Replaced by (M-33410, SRT, "Epidermal inclusion cyst").

111263

Fibroadenomatoid hyperplasia

Excessive proliferation of fibroadenoma tissue.

111264

Fibroadenolipoma

A lipoma with an abundant stroma of fibrous tissue.

111265

Foreign body (reaction)

Retired. Replaced by (M-44140, SRT, "Foreign body (reaction) ").

111269

Galactocele

Retention cyst caused by occlusion of a lactiferous duct

Retired. Replaced by (D7-90364, SRT, "Galactocele").

111271

Hemangioma - nonparenchymal, subcutaneous

A congenital anomaly that leads to a proliferation of blood vessels leading to a mass that resembles a neoplasm, not located in parenchymal areas but subcutaneous

Retired. Replaced by (D3-F0620, SRT, "Hemangioma of subcutaneous tissue").

111273

Hyperplasia, usual

Retired. Replaced by (M-72000, SRT, "Hyperplasia, usual").

111277

Juvenile papillomatosis

A form of fibrocystic disease in young woman with florid and sclerosing adenosis that microscopically may suggest carcinoma.

111278

Lactating adenoma

Enlarging masses during lactation. A circumscribed benign tumor composed primarily of glandular structures with scanty stroma, with prominent secretory changes in the duct

Retired. Replaced by (M-82040, SRT, "Lactating adenoma").

111279

Lactational change

Changes related to the process of lactation.

111281

Large duct papilloma

A papilloma pertaining to large mammary duct.

111283

Myofibroblastoma

Solitary or multiple tumors of muscles and fibrous tissues, or tumors composed of myofibroblasts

Retired. Replaced by (M-88250, SRT, "Myofibroblastoma").

111284

Microglandular adenosis

Irregular clusters of small tubules are present in adipose or fibrous tissue, resembling tubular carcinoma but lacking stromal fibroblastic proliferation.

111285

Multiple Intraductal Papillomas

Papilloma typically involving an aggregate of adjacent ducts in the periphery of the breast, likely representing involvement of several foci of one or two duct systems.

111286

No abnormality

No abnormality.

111287

Normal breast tissue

Normal breast tissue.

111288

Neurofibromatosis

Condition in which there are tumors of various sizes on peripheral nerves. They may be neuromas or fibromas

Retired. Replaced by (M-95401, SRT, "Neurofibromatosis").

111290

Oil cyst (fat necrosis cyst)

A cyst resulting from the loss of the epithelial lining of a sebaceous dermoid or lacteal cyst.

111291

Post reduction mammoplasty

Breast tissue with characteristics of a benign nature, following breast reduction surgery.

111292

Pseudoangiomatous stromal hyperplasia

A benign stromal lesion composed of intermixed stromal and epithelial elements. The lobular and duct structures of the breast parenchyma are separated by an increased amount of stroma, non specific proliferative epithelial changes include hyperplasia of duct and lobular epithelium often with accentuation of myoepithelial cells and aprocine metaplasia with or without cyst formation.

111293

Radial scar

An nonencapsulated stellate lesion consisting of a fibroelastic core and radiating bands of fibrous connective tissue containing lobules manifesting adenosis and ducts with papillary or diffuse intraductal hyperplasia

Retired. Replaced by (M-78731, SRT, "Radial scar").

111294

Sclerosing adenosis

Prominent interductal fibrosis of the terminal ductules

Retired. Replaced by (M-74220, SRT, "Sclerosing adenosis").

111296

Silicone granuloma

Nodular inflammatory lesions due to the presence of silicone in the breast tissue.

111297

Nipple Characteristic

The morphologic status of the nipple.

111298

Virginal hyperplasia

Spontaneous excessive proliferation of breast tissue, usually found in younger women.

111299

Peripheral duct papillomas

Papilloma(s) pertaining the peripheral ducts.

111300

Axillary node with lymphoma

Axillary node with lymphoid tissue neoplasm.

111301

Axillary nodal metastases

Metastatic disease to the axillary node.

111302

Angiosarcoma

A malignant neoplasm occurring most often in breast and skin, believed to originate from endothelial cells of blood vessels, microscopically composed of closely packed round or spindle shaped cells, some of which line small spaces resembling vascular clefts

Retired. Replaced by (M-91203, SRT, "Angiosarcoma").

111303

Blood vessel (vascular) invasion

Histological changes to the vascular system related to an invasive process.

111304

Carcinoma in children

Carcinoma of the breast found in patients less than 20 years of age.

111305

Carcinoma in ectopic breast

A carcinoma found in supernumerary breasts and aberrant breast tissue.

111306

Carcinoma with endocrine differentiation

A carcinoma that synthesizes substances, including hormones, not considered to be normal products of the breast.

111307

Basal cell carcinoma of nipple

A basal cell carcinoma that arises in the nipple of the breast.

111308

Carcinoma with metaplasia

Retired. Replaced by (M-85733, SRT, "Carcinoma with metaplasia").

111309

Cartilaginous and osseous change

Tissue changes to bones and cartilage.

111310

Carcinoma in pregnancy and lactation

Carcinoma of the breast presenting during pregnancy or lactation.

111311

Carcinosarcoma

A malignant neoplasm that contains elements of carcinoma and sarcoma, so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue

Retired. Replaced by (M-89803, SRT, "Carcinosarcoma").

111312

Intraductal comedocarcinoma with necrosis

Comedocarcinoma of a duct with areas of necrotic tissue.

111313

Intraductal carcinoma, low grade

A non-invasive carcinoma restricted to the glandular lumen characterized by less aggressive malignant cytologic features and behavior.

111314

Intraductal carcinoma micro-papillary

Retired. Replaced by (M-85072, SRT, "Intraductal carcinoma micro-papillary").

111315

Intracystic papillary carcinoma

A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells found in a cyst.

111316

Invasive and in-situ carcinoma

Carcinoma with both characteristics of localized and spreading disease.

111317

Invasive lobular carcinoma

Retired. Replaced by (M-85203, SRT, "Invasive lobular carcinoma").

111318

Leukemic infiltration

Mammary infiltrates as a secondary manifestation in patients with established leukemia.

111320

Lympathic vessel invasion

Histological changes to the lymphatic system related to an invasive process.

111321

Lymphoma

A heterogeneous group of neoplasms arising in the reticuloendoethelial and lymphatic systems

Retired. Replaced by (M-95903, SRT, "Lymphoma").

111322

Occult carcinoma presenting with axillary lymph node metastases

A small carcinoma, either asymptomatic or giving rise to metastases without symptoms due to the primary carcinoma presenting with metastatic disease in the axillary lymph nodes.

111323

Metastatic cancer to the breast

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a non-mammary malignant neoplasm.

111324

Metastatic cancer to the breast from the colon

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the colon.

111325

Metastatic cancer to the breast from the lung

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the lung.

111326

Metastatic melanoma to the breast

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a melanoma.

111327

Metastatic cancer to the breast from the ovary

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the ovary.

111328

Metastatic sarcoma to the breast

A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a sarcoma.

111329

Multifocal intraductal carcinoma

Multiple foci of non-invasive carcinoma restricted to the glandular lumen.

111330

Metastatic disease to axillary node

A malignant lesion in an axillary node arising from a non-axillary neoplasm.

111331

Malignant fibrous histiocytoma

Retired. Replaced by (M-88303, SRT, "Malignant fibrous histiocytoma").

111332

Multifocal invasive ductal carcinoma

Multiple sites of ductal carcinoma.

111333

Metastasis to an intramammary lymph node

A malignant lesion in a intramammary lymph node arising from a non-intramammary lymph node neoplasm.

111334

Malignant melanoma of nipple

A malignant melanoma of the skin that arises in the nipple of the breast.

111335

Neoplasm of the mammary skin

Retired. Replaced by (D0-F035F, SRT, "Neoplasm of the mammary skin").

111336

Papillary carcinoma in-situ

Retired. Replaced by (M-80502, SRT, "Papillary carcinoma in-situ").

111338

Recurrent malignancy

Recurrent malignancy.

111340

Squamous cell carcinoma of the nipple

Squamous cell carcinoma to the terminal portion of the alveolar.

111341

Intraductal carcinoma, high grade

A non-invasive carcinoma restricted to the glandular lumen characterized by more aggressive malignant cytologic features and behavior.

111342

Invasive cribriform carcinoma

Retired. Replaced by (M-82013, SRT, "Invasive cribriform carcinoma").

111343

Angular margins

An indication that some or all of the margin of a lesion has sharp corners, often forming acute angles.

111344

Fine pleomorphic calcification

Calcifications that vary in sizes and shapes and are usually smaller than0.5 mm in diameter.

111345

Macrocalcifications

Coarse calcifications that are 0.5 mm or greater in size.

111346

Calcifications within a mass

An indicator that calcifications are imbedded within a mass.

111347

Calcifications outside of a mass

An indicator that calcifications are imaged outside of a mass finding.

111350

Breast background echotexture

Tissue composition of the breast noted on sonography.

111351

Homogeneous fat echotexture

Fat lobules and uniformly echogenic bands of supporting structures comprise the bulk of breast tissue.

111352

Homogeneous fibroglandular echotexture

A uniformly echogenic layer of fibroglandular tissue is seen beneath a thin layer of subcutaneous fat.

111353

Heterogeneous echotexture

The breast texture is characterized by multiple small areas of increased and decreased echogenicity.

111354

Orientation

Referential relationship of the finding to the imaging device as noted on sonography.

111355

Parallel

The long axis of a lesion parallels the skin line ("wider-than-tall" or in a horizontal orientation).

111356

Not parallel

The anterior-posterior or vertical dimension is greater than the transverse or horizontal dimension.

111357

Lesion boundary

The lesion boundary describes the transition zone between themas and the surrounding tissue.

111358

Abrupt interface

The sharp demarcation between the lesion and surrounding tissue can be imperceptible or a distinct well-defined echogenic rim of any thickness.

111359

Echogenic halo

There is no sharp demarcation between the mass and the surrounding tissue, which is bridged by an echogenic transition zone.

111360

Echo pattern

An imaging characteristic of resonance noted during sonography.

111361

Anechoic

Without internal echoes.

111362

Hyperechoic

Having increased echogenicity relative to fat or equal to fibroglandular tissue.

111363

Complex

Mass contains both anechoic and echogenic components.

111364

Hypoechoic

Defined relative to fat; masses are characterized by low-level echoes throughout. E.g., appearance of a complicated cyst or fibroadenoma.

111365

Isoechoic

Having the same echogenicity as fat (a complicated cyst or fibroadenoma may be isoechoic or hypoechoic).

111366

Posterior acoustic features

The attenuation characteristics

of a mass with respect to its acoustic transmission.

111367

No posterior acoustic features

No posterior shadowing or enhancement.

111368

Posterior enhancement

Increased posterior echoes.

111369

Posterior shadowing

Decreased posterior echoes; edge shadows are excluded.

111370

Combined posterior enhancement and shadowing

More than one pattern of posterior attenuation, both shadowing and enhancement.

111371

Identifiable effect on surrounding tissues

Sonographic appearance of adjacent structures relative to a mass finding.

111372

Vascularity

Characterization of vascularization in region of interest.

111373

Vascularity not present

Vascularity not evident, such as on ultrasound.

111374

Vascularity not assessed

Vascularity not evaluated.

111375

Vascularity present in lesion

Vascularity on imaging is seen within a lesion.

111376

Vascularity present immediately adjacent to lesion

Vascularity on imaging is seen immediately adjacent to a lesion.

111377

Diffusely increased vascularity in surrounding tissue

Vascularity on imaging is considered diffusely elevated within the surrounding breast tissue.

111380

Correlation to other Findings

Relationship of the new anomaly to other clinical or imaging anomalies.

111381

Correlates to physical exam findings

An indication that the current imaging finding relates to a finding from a clinical breast exam.

111382

Correlates to mammography findings

An indication that the current imaging finding relates to a finding from a mammography exam.

111383

Correlates to MRI findings

An indication that the current imaging finding relates to a finding from a breast MRI exam.

111384

Correlates to ultrasound findings

An indication that the current imaging finding relates to a finding from a breast ultrasound exam.

111385

Correlates to other imaging findings

An indication that the current imaging finding relates to a finding from an imaging exam.

111386

No correlation to other imaging findings

An indication that the current imaging finding has no relation to findings from any other imaging exam.

111387

No correlation to clinical findings

An indication that the current imaging finding has no relation to any other clinical findings.

111388

Malignancy Type

Classification of the cancer as invasive, DCIS, or other.

111389

Invasive breast carcinoma

A malignancy that has spread beyond an area of focus.

111390

Other malignancy type

A breast cancer with malignant pathology findings that are not classified as invasive or in situ.

111391

Menstrual Cycle Phase

A specific timeframe during menses.

111392

1st week

In the first week of the menstrual cycle phase, that is, one week following menses.

111393

2nd week

In the second week of the menstrual cycle phase, that is, two weeks following menses.

111394

3rd week

In the third week of the menstrual cycle phase, that is, three weeks following menses.

111395

Estimated Timeframe

An estimated period of time.

111396

< 3 months ago

An event occurred less than 3 months ago.

111397

4 months to 1 year ago

An event occurred between 4 months and 1 year ago.

111398

> 1 year ago

An event occurred longer than 1 year ago.

111399

Timeframe uncertain

The timing of an event is not recalled.

111400

Breast Imaging Report

Report title for the diagnostic report for one or more breast imaging or intervention procedures.

111401

Reason for procedure

Concept name for the description of why a procedure has been performed.

111402

Clinical Finding

A finding during clinical examination (i.e., history and physical examination) such as pain, palpable mass or discharge.

111403

Baseline screening mammogram

First screening mammogram taken for patient that is used as a comparison baseline for further examinations.

111404

First mammogram ever

First mammogram taken for a patient without regard to whether it was for screening or a diagnostic procedure.

111405

Implant type

Concept name for the material of which a breast prosthetic device is constructed.

111406

Number of similar findings

A numeric count of findings classified as similar in nature.

111407

Implant finding

Concept name for the status of a breast prosthetic device as noted by imaging.

111408

Film Screen Mammography

Mammogram using traditional X-Ray film.

111409

Digital Mammography

Mammogram using a digital image acquisition system.

111410

Surgical consult

Referred for evaluation by a surgeon.

111411

Mammography CAD

Computer aided detection and/or computer aided diagnosis for mammography.

111412

Narrative Summary

Concept name for a text-based section of a report.

111413

Overall Assessment

A title for a report section that summarizes all interpretation results for a report with one overriding assessment. E.g., benign or negative.

111414

Supplementary Data

Concept name for a collection of supporting evidence for a report.

111415

Additional evaluation requested from prior study

Prior study indicates that additional imaging be performed to further evaluate a suspicious or questionable anatomic region.

111416

Follow-up at short interval from prior study

The prior study recommended a follow-up breast imaging exam in 1 to 11 months (generally in 6 months).

111417

History of breast augmentation, asymptomatic

Prior breast augmentation (breast enlargement) and is not presenting with any symptoms.

111418

Review of an outside study

Review or second opinion made on an image performed outside of the facility.

111419

Additional evaluation requested from abnormal screening exam

Additional breast imaging performed at the time of the patient's screening mammogram.

111420

History of benign breast biopsy

Patient has had previous benign breast biopsies.

111421

Personal history of breast cancer with breast conservation therapy

Patient has had a prior surgery such as a lumpectomy or quadrantectomy to remove malignant breast tissue, but breast tissue remains.

111423

Physical Examination Results

The results of a physical examination performed on the patient, possibly including the results of inspection, palpation, auscultation, or percussion.

111424

Comparison to previous findings

The result of assessing the current imaging exam in comparison to previous imaging exams.

111425

Intraluminal filling defect

An abnormality observed during ductography where the ductal system within the breast fills in an abnormal pattern. Ductography is an imaging exam in which a radio opaque contrast media is introduced into the ductal system of the breast through the nipple and images of the ductal system are obtained.

111426

Multiple filling defect

During ductography an observation of more than one filling abnormality within the breast ductal system.

111427

Abrupt duct termination

An abnormality observed during ductography where the ductal system within the breast terminates in an unusual fashion.

111428

Extravasation

Abnormal flowage of contrast media within the breast noted on ductography.

111429

Duct narrowing

An abnormality observed during ductography where the ductal system within the breast appears narrow.

111430

Cyst fill

During ductography an observation of the contrast media filling a cyst within the breast.

111431

Instrument Approach

The area and line within the anatomy through which a needle or instrument passes during an interventional procedure.

111432

Inferolateral to superomedial

The line within the anatomy from the lower outer to the upper inner aspect. E.g., through which a needle or instrument passes in an interventional procedure.

111433

Inferomedial to superolateral

The line within the anatomy from the lower inner to the upper outer aspect. E.g., through which a needle or instrument passes in an interventional procedure.

111434

Superolateral to inferomedial

The line within the anatomy from the upper outer to the lower inner aspect. E.g., through which a needle or instrument passes in an interventional procedure.

111435

Superomedial to inferolateral

The line within the anatomy from the upper inner to the lower outer aspect. E.g., through which a needle or instrument passes in an interventional procedure.

111436

Number of passes

The number of times a biopsy instrument is passed through an area of interest.

111437

Number of specimens

The number of biopsy specimens obtained from an interventional procedure.

111438

Needle in target

An indicator of whether or not a biopsy or localizing needle in an interventional procedure is seen to be in the area of interest.

111439

Number of needles around target

The number of localizing needles placed around the area of interest in an interventional procedure.

111440

Incision made

An indicator of whether or not an incision was made in the anatomy during an interventional procedure.

111441

Microclip placed

An indicator of whether or not a radio opaque microclip was placed in the anatomy during an interventional procedure.

Retired. Replaced by (111123, DCM, "Marker placement")

111442

Confirmation of target

An indicator of the degree of success of an interventional procedure.

111443

Target completely contained in the specimen

An indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen.

111444

Target partially obtained in the specimen

An indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen.

111445

Target not in the specimen

An indicator that following an interventional procedure the area of interest is not seen in the resultant biopsy specimen.

111446

Calcifications seen in the core

An indicator that following an interventional procedure the targeted calcifications are noted in the resultant biopsy specimen.

111447

Lesion completely removed

An indicator that during an interventional procedure the area of interest was fully excised and is noted in the resultant biopsy specimen.

111448

Lesion partially removed

An indicator that during an interventional procedure the area of interest was partially excised and is noted in the resultant biopsy specimen.

111449

Fluid obtained

An indicator that during an interventional procedure fluid was successfully aspirated.

111450

Light brown color

Color that is a light shade of brown.

111451

Dark red color

Color that is a dark shade of red.

111452

Dark brown color

Color that is a dark shade of brown.

111453

Bright red color

Color that is a bright shade of red.

111454

Blood tinged color

Color that is tinged with the color of blood.

111455

Occult blood test result

An indicator of whether or not the fluid obtained during an interventional procedure contains red blood cells.

111456

Action on fluid

An indicator of whether or not fluid during an interventional procedure was sent for cytological analysis or simply discarded.

111457

Sent for analysis

An indicator that fluid obtained during an interventional procedure was sent to a laboratory for analysis.

111458

Discarded

An indicator that fluid obtained during an interventional procedure was discarded.

111459

Mass with calcifications

A radiopaque density noted during diagnostic imaging that has associated calcific densities.

111460

Complex cyst

A fluid-filled sac with greater than normal characteristics.

111461

Intracystic lesion

A tumor within a cyst.

111462

Solid mass

A tumor or lesion.

111463

Supplementary Data for Intervention

Supporting evidence for interpretation results of an interventional procedure.

111464

Procedure Modifier

A descriptor that further qualifies or characterizes a type of procedure.

111465

Needle Gauge

Needle size (diameter) characterization. E.g., of a biopsy needle.

111466

Severity of Complication

An indicator of the gravity of a problem experienced by a patient, related to a procedure that was performed.

111467

Needle Length

Distance from the hub or bushing to the tip of the needle.

111468

Pathology Results

The collection of observations and findings from pathologic analysis.

111469

Sampling DateTime

The date and time that the sample was collected from the patient.

111470

Uninvolved

Indicates that the margin of the biopsy specimen was not involved with the tumor.

111471

Involved

Indicates that the margin of the biopsy specimen was involved with the tumor.

111472

Nipple involved

Indicates whether the nipple was involved in an interventional procedure or pathologic analysis.

111473

Number of nodes removed

Indicates the number of lymph nodes removed.

111474

Number of nodes positive

Indicates the number of lymph nodes removed that contain cancer cells.

111475

Estrogen receptor

The result of a test for the presence of a protein that binds with estrogen.

111476

Progesterone receptor

The result of a test for the presence of a protein that binds with progesterone.

111477

S Phase

Indicates the percentage of cells in S phase. Cell division is defined by phases; the S phase is the stage during which DNA replicates.

111478

Non-bloody discharge (from nipple)

The visible emission of non-bloody fluid from the nipple.

111479

Difficult physical/clinical examination

The inability to discern normal versus abnormal breast tissue during palpation.

111480

Cancer elsewhere

An indication that a patient has or had a malignant occurrence in an area of the body other than the breast.

111481

Saline implant

A salt water filled prosthetic device implanted in the breast.

111482

Polyurethane implant

A polymer based (plastic) prosthetic device implanted in the breast.

111483

Percutaneous silicone injection

The introduction of polymeric organic silicon based material through the skin, as for breast augmentation or reconstruction.

111484

Combination implant

A prosthetic device that contains more than one material implanted in the breast.

111485

Pre-pectoral implant

A breast implant placed in front of the pectoralis major muscle.

111486

Retro-pectoral implant

A breast implant placed behind the pectoralis major muscle.

111487

Mammographic (crosshair)

Using X-Ray technique and a superimposed set of crossed lines for detection or placement.

111488

Mammographic (grid)

Using X-Ray technique and a superimposed aperture for detection or placement.

111489

Palpation guided

Using physical touch for detection or placement.

111490

Vacuum assisted

The performance of a biopsy procedure using a vacuum device attached to the biopsy needle.

111491

Abnormal discharge

Unusual or unexpected emission of fluid.

111492

No complications

Having experienced no adverse medical conditions related to or resulting from an interventional procedure.

111494

Stage 0

TNM grouping of tumor stage, from AJCC, where primary tumor is Tis, regional lymph node is N0, and distant metastasis is M0.

111495

Stage I

TNM grouping of tumor stage, from AJCC, where primary tumor is T1, regional lymph node is N0, and distant metastasis is M0.

111496

Stage IIA

TNM grouping of tumor stage, from AJCC, where primary tumor is T0 or T1, with regional lymph node N1 and distant metastasis is M0, or T2 with N0 and M0.

111497

Stage IIB

TNM grouping of tumor stage, from AJCC, where primary tumor is T2, with regional lymph node N1 and distant metastasis is M0, or T3 with N0 and M0.

111498

Stage IIIA

TNM grouping of tumor stage, from AJCC, where primary tumor is T0, T1 or T2, with regional lymph node N2 and distant metastasis is M0, or T3 with N1 or N2 and M0.

111499

Stage IIIB

TNM grouping of tumor stage, from AJCC, where primary tumor is T4, regional lymph node is N0, N1 or N2, and distant metastasis is M0.

111500

Stage IIIC

TNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is N3, and distant metastasis is M0.

111501

Stage IV

TNM grouping of tumor stage, from AJCC, where primary tumor is any T value, regional lymph node is any N value, and distant metastasis is M1.

111502

Bloom-Richardson Grade

Histologic tumor grade (sometimes called Scarff-Bloom-Richardson grade) is based on the arrangement of the cells in relation to each other -- whether they form tubules, how closely they resemble normal breast cells (nuclear grade) and how many of the cancer cells are in the process of dividing (mitotic count).

111503

Normal implants

Breast prosthetic devices are intact, not leaking, and are in a normal shape and form.

111504

Asymmetric implants

Breast prosthetic devices are not symmetric, equal, corresponding in form, or are in one breast (unilateral).

111505

Calcified implant

Fibrous or calcific contracture of the tissue capsule that forms around a breast prosthetic device.

111506

Distorted implant

Breast prosthetic device is twisted out of normal shape or form.

111507

Silicone-laden lymph nodes

Silicone from breast prosthetic device found in lymphatic tissue.

111508

Free silicone

Silicone found in breast tissue outside of the prosthetic capsule or implant membrane.

111509

Herniated implant

Protrusion of part of the structure normally encapsulating the content of the breast prosthetic device.

111510

Explantation

Evidence of removal of a breast prosthetic device.

111511

Relevant Patient Information for Breast Imaging

Historical patient health information of interest to the breast health clinician.

111512

Medication History

Information regarding usage by the patient of certain medications, such as hormones.

Retired. Replaced by (10160-0, LN, "History Of Medication Use")

111513

Relevant Previous Procedures

Interventional or non-interventional procedures previously performed on the patient, such as breast biopsies.

111514

Relevant Indicated Problems

Abnormal conditions experienced by the patient that serve as the reason for performing a procedure, such as a breast exam.

Retired. Replaced by (11450-4, LN, "Problem List")

111515

Relevant Risk Factors

Personal, familial, and other health factors that may indicate an increase in the patient's chances of developing a health condition or disease, such as breast cancer.

111516

Medication Type

A classification of a medicinal substance, such as hormonal contraceptive or antibiotic.

111517

Relevant Patient Information

Historical patient health information for general purpose use.

111518

Age when first menstrual period occurred

The age of the patient at the first occurrence of menses.

111519

Age at First Full Term Pregnancy

The age of the patient at the time of her first full term pregnancy.

111520

Age at Menopause

The age of the patient at the cessation of menses.

111521

Age when hysterectomy performed

The age of the patient at the time her uterus was removed.

111522

Age when left ovary removed

The age of the patient at the time she had her left ovary removed.

111523

Age when right ovary removed

The age of the patient at the time she had her right ovary removed.

111524

Age Started

The age of a patient on the first occurrence of an event, such as the first use of a medication.

111525

Age Ended

The age of a patient on the last occurrence of an event, such as the last use of a medication.

111526

DateTime Started

The date and time of the first occurrence of an event, such as the first use of a medication.

111527

DateTime Ended

The date and time of the last occurrence of an event, such as the last use of a medication.

111528

Ongoing

An indicator of whether an event is still in progress, such as the use of a medication or substance, or environmental exposure.

111529

Brand Name

Product name of a device or substance, such as medication, to identify it as the product of a single firm or manufacturer.

111530

Risk Factor modifier

A descriptor that further qualifies or characterizes a risk factor.

111531

Previous Procedure

A prior non-interventional exam or interventional procedure performed on a patient.

111532

Pregnancy Status

Describes the pregnancy state of a referenced subject.

111533

Indicated Problem

A symptom experienced by a patient that is used as the reason for performing an exam or procedure.

111534

Role of person reporting

The function of the individual who is reporting information on a patient, which could be a specific health care related profession, the patient him/herself, or a relative or friend.

111535

DateTime problem observed

The date and time that a symptom was noted.

111536

DateTime of last evaluation

The date and time of the most recent evaluation of an indicated problem.

111537

Family Member with Risk Factor

A patient's biological relative who exhibits a health factor that may indicate an increase in the patient's chances of developing a particular disease or medical problem.

111538

Age at Occurrence

The age at which an individual experienced a specific event, such as breast cancer.

111539

Menopausal phase

The current stage of an individual in her gynecological development.

111540

Side of Family

An indicator of paternal or maternal relationship.

111541

Maternal

Relating to biological female parentage.

111542

Unspecified gynecological hormone

A gynecological hormone for which the specific type is not specified. E.g., contraceptive, estrogen, Tamoxifen.

111543

Breast feeding history

An indicator of whether or not a patient ever provided breast milk to her offspring.

111544

Average breast feeding period

The average length of time that a patient provided breast milk to her offspring.

111545

Substance Use History

Information regarding usage by the patient of certain legal or illicit substances.

111546

Used Substance Type

A classification of a substance, such as alcohol or a legal or illicit drug.

111547

Environmental Exposure History

Information regarding exposure of the patient to potentially harmful environmental factors.

111548

Environmental Factor

A classification of a potentially harmful substance or gas in a subject's environment, such as asbestos, lead, or carcinogens.

111549

Previous Reports

Previous Structured Reports that could have relevant information for a current imaging service request.

111550

Personal breast cancer history

An indication that a patient has had a previous malignancy of the breast.

111551

History of endometrial cancer

Indicates a previous occurrence of cancer of the lining of the uterus.

111552

History of ovarian cancer

Indicates a previous occurrence of cancer of the lining of the ovary.

111553

History of high risk lesion on previous biopsy

Indicates a prior diagnosis of pre-cancerous cells or tissue removed for pathologic evaluation.

111554

Post menopausal patient

A female patient whose menstrual periods have ceased.

111555

Late child bearing (after 30)

A female patient whose first child was born after the patient was 30 years old.

111556

BRCA1 breast cancer gene

The first level genetic marker indicating risk for breast cancer.

111557

BRCA2 breast cancer gene

The second level genetic marker indicating risk for breast cancer.

111558

BRCA3 breast cancer gene

The third level genetic marker indicating risk for breast cancer.

111559

Weak family history of breast cancer

A patient's biological aunt, grandmother, or female cousin was diagnosed with breast cancer. Definition from BI-RADS®.

111560

Intermediate family history of breast cancer

A patient's biological mother or sister was diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®.

111561

Very strong family history of breast cancer

A patient's biological mother or sister was diagnosed with breast cancer before they had gone through menopause, or more than one of the patient's first-degree relatives (biological mother or sister) were diagnosed with breast cancer after they had gone through menopause. Definition from BI-RADS®.

111562

Family history of prostate cancer

Previous diagnosis of a malignancy of the prostate gland in a biological relative.

111563

Family history unknown

The health record of a patient's biological relatives is not known.

111564

Nipple discharge cytology

The study of cells obtained from fluid emitted from the breast.

111565

Uterine malformations

A developmental abnormality resulting in an abnormal shape of the uterus.

111566

Spontaneous Abortion

A naturally occurring premature expulsion from the uterus of the products of conception - the embryo or a nonviable fetus.

111567

Gynecologic condition

An ailment/abnormality or state of the female reproductive tract.

111568

Gynecologic surgery

A surgical operation performed on any portion of the female reproductive tract.

111569

Previous LBW or IUGR birth

Prior pregnancy with a low birth weight baby or a fetus with Intrauterine Growth Restriction or Retardation.

111570

Previous fetal malformation/syndrome

History of at least one prior pregnancy with fetal anatomic abnormality(s).

111571

Previous RH negative or blood dyscrasia at birth

History of delivering a Rhesis Isoimmunization affected child(ren) or a child(ren) with another blood disorder.

111572

History of multiple fetuses

History of at least one pregnancy that contained more than one fetus. E.g., twins, triplets, etc..

111573

Current pregnancy, known or suspected malformations/syndromes

At least one fetus of this pregnancy has an anatomic abnormality(s) that is known to exist, or a "marker" is present that suggests the abnormality(s) may be present.

111574

Family history, fetal malformation/syndrome

Biological relatives have previously conceived a fetus with an anatomic abnormality(s).

111575

High

A subjective descriptor for an elevated amount of exposure, use, or dosage, incurring high risk of adverse effects.

111576

Medium

A subjective descriptor for a moderate amount of exposure, use, or dosage, incurring medium risk of adverse effects.

111577

Low

A subjective descriptor for a limited amount of exposure, use, or dosage, incurring low risk of adverse effects.

111578

Dose frequency

A measurement of the rate of occurrence of which a patient takes a certain medication.

111579

Rate of exposure

The quantity per unit of time that a patient was or is being exposed to an environmental irritant.

111580

Volume of use

The quantity per unit of time that a medication or substance was or is being used.

111581

Relative dose amount

A qualitative descriptor for the amount of a medication that was or is being taken.

111582

Relative amount of exposure

A qualitative descriptor for the amount of present or past exposure to an environmental irritant.

111583

Relative amount of use

A qualitative descriptor for the amount of a medication or substance that was or is being used.

111584

Relative dose frequency

A qualitative descriptor for the frequency with which a medication was or is being taken.

111585

Relative frequency of exposure

A qualitative descriptor for the frequency of present or past exposure to an environmental irritant.

111586

Relative frequency of use

A qualitative descriptor for the frequency with which a medication or substance was or is being used.

111587

No known exposure

Patient is not known to have been exposed to or used the substance or medication.

111590

Recall for technical reasons

Patient returns for additional images to improve the quality of the most recent exam.

111591

Recall for imaging findings

Patient returns for additional images to clarify findings from the most recent exam.

111592

Recall for patient symptoms/ clinical findings

Patient returns for additional images to clarify symptoms or signs reported by the patient or a healthcare professional at the time of the most recent exam.

111593

LBW or IUGR

Number of births with low birth weight or intrauterine growth restriction.

111601

Green filter

Filter that transmits green light while blocking the other colors, typically centered at 510-540 nm

Retired. Replaced by (A-010E2, SRT, "Green optical filter")

111602

Red filter

Filter that transmits red light while blocking the other colors, typically centered at 630-680 nm

Retired. Replaced by (A-010DF, SRT, "Red optical filter")

111603

Blue filter

Filter that transmits blue while blocking the other colors, typically centered at 460-480 nm

Retired. Replaced by (A-010DA, SRT, "Blue optical filter")

111604

Yellow-green filter

A filter of 560nm that is used for retinal imaging and can provide good contrast and good visibility of the retinal vasculature

Retired. Replaced by (A-010E0, SRT, "Yellow-green optical filter")

111605

Blue-green filter

A filter of 490nm that is used for retinal imaging because of excessive scattering of some retinal structures at very short wavelengths

Retired. Replaced by (A-010D8, SRT, "Blue-green optical filter")

111606

Infrared filter

Filter that transmits the infrared spectrum, which is light that lies outside of the visible spectrum, with wavelengths longer than those of red light, while blocking visible light

Retired. Replaced by (A-010DC, SRT, "Infrared optical filter")

111607

Polarizing filter

A filter that reduces reflections from non-metallic surfaces such as glass or water by blocking light waves that are vibrating at selected angles to the filter.

Retired. Replaced by (A-010E1, SRT, "Polarizing optical filter")

111609

No filter

No filter used.

111621

Field 1 for Joslin 3 field

Joslin NM-1 is a 45 degree field focused centrally between the temporal margin of optic disc and the center of the macula: Center the camera on the papillomacular bundle midway between the temporal margin of the optic disc and the center of the macula. The horizontal centerline of the image should pass directly through the center of the disc.

111622

Field 2 for Joslin 3 field

Joslin NM-2 is a 45 degree field focused superior temporal to the optic disc: Center the camera laterally approximately one-half disc diameter temporal to the center of the macula. The lower edge of the field is tangent to a horizontal line passing through the upper edge of the optic disc. The image is taken temporal to the macula but includes more retinal nasal and superior to the macula than standard field 2.

111623

Field 3 for Joslin 3 field

Joslin NM-3 is a 45 degree field focused nasal to the optic disc: This field is nasal to the optic disc and may include part of the optic disc. The horizontal centerline of the image should pass tangent to the lower edge of the optic disc.

111625

Diffuse direct illumination

A broad or "soft" light supplied from a single source.

111626

Scheimpflug Camera

A slit reflected light microscope, which has the ability to form an image of the back scattered light from the eye in a sagittal plane. Scheimpflug cameras are able to achieve a wide depth of focus by employing the "Sheimpflug principle" where the lens and image planes are not parallel with each other. Rotating Sheimplug cameras are able to generate three-dimensional images and calculate measurements of the anterior chamber of the eye.

111627

Scotopic light

Lighting condition approximately 0.04 lux.

111628

Mesopic light

Lighting condition approximately 4 lux.

111629

Photopic light

Lighting condition approximately 40 lux.

111630

Dynamic light

Acquisition preceded by intense light.

111631

Average Glandular Dose

Calculated from values of entrance exposure in air, the X-Ray beam quality (half-value layer), and compressed breast thickness, is the energy deposited per unit mass of glandular tissue averaged over all the glandular tissue in the breast.

111632

Anode Target Material

The primary material in the anode of an X-Ray source.

111633

Compression Thickness

The average thickness of the body part examined when compressed, if compression has been applied during X-Ray exposure.

111634

Half Value Layer

Thickness of Aluminum required to reduce the X-Ray output at the patient entrance surface by a factor of two.

111635

X-Ray Grid

An anti-scatter device based on radiation absorbing strips above the detector. E.g., in the patient support.

111636

Entrance Exposure at RP

Exposure measurement in air at the reference point that does not include back scatter, according to MQCM 1999.

111637

Accumulated Average Glandular Dose

Average Glandular Dose to a single breast accumulated over multiple images.

111638

Patient Equivalent Thickness

Value of the control variable used to parametrize the Automatic Exposure Control (AEC) closed loop. E.g., "Water Value".

111641

Fixed grid

An X-Ray Grid that does not move during exposure.

111642

Focused grid

An X-Ray Grid with radiation absorbing strips that are focused toward the focal spot, to eliminate grid cutoff.

111643

Reciprocating grid

An X-Ray Grid that is designed to move during exposure, to eliminate the appearance of grid lines on the image.

111644

Parallel grid

An X-Ray Grid with radiation absorbing strips that are parallel to each other and that is used only with long source to image distances.

111645

Crossed grid

An X-Ray Grid with crossed radiation absorbing strips used for more complete cleanup of scatter radiation.

111646

No grid

No X-Ray Grid was used due to low scatter conditions.

111671

Spectacle Prescription Report

The spectacle prescription for a patient.

111672

Add Near

Refractive measurements of the eye to correct for inability to focus at near while wearing the distance prescription.

111673

Add Intermediate

Refractive measurements of the eye to correct for inability to focus at intermediate distance while wearing the distance prescription.

111674

Add Other

Refractive measurements of the eye to correct for inability to focus at the specified distance while wearing the distance prescription.

111675

Horizontal Prism Power

The power of a prism to bend light in the horizontal direction, in prism diopters.

111676

Horizontal Prism Base

Direction of the base of a horizontal prism -- either in (toward the nose), or out (away from the nose).

111677

Vertical Prism Power

The power of a prism to bend light in the vertical direction, in prism diopters.

111678

Vertical Prism Base

Direction of the base of a vertical prism -- either up, or down.

111679

Distance Pupillary Distance

Distance in mm between the pupils when the patient's object of regard is in the distance.

111680

Near Pupillary Distance

Distance in mm between the pupils when the patient's object of regard is at near.

111685

Autorefraction Visual Acuity

A patient's vision with the correction measured by an autorefractor in place.

111686

Habitual Visual Acuity

A patient's vision with whichever vision correction the patient customarily wears.

111687

Prescription Visual Acuity

A patient's vision with the final spectacle prescription in place.

111688

Right Eye Rx

The spectacle prescription for the right eye.

111689

Left Eye Rx

The spectacle prescription for the left eye.

111690

Macular Grid Thickness and Volume Report

A macular grid thickness and volume report for a patient. The macular grid is an analytic tool described in PS3.1.

111691

Number of Images Used for Macular Measurements

Number of images used for the macular grid measurement.

111692

Number of Samples Used per Image

Number of samples used per Image for analysis.

111693

Analysis Quality Rating

A numeric rating of the quality of the entire analysis with respect to grading and diagnostic purposes.

Higher numbers indicate greater quality.

111694

Image Set Quality Rating

A numeric rating of the quality of an entire image set with respect to grading and diagnostic purposes.

Higher numbers indicate greater quality.

111695

Interfering Tears or Drops

Tear film or drops affecting test quality.

111696

Visual Fixation Quality During Acquisition

The assessment of the centricity and persistence of the visual fixation (direction of gaze) during the acquisition.

111697

Visual Fixation Quality Problem

The reason why the patient's visual fixation was not steady or was indeterminate.

111698

Ophthalmic Macular Grid Problem

The reason why the macular grid measurements may be questionable.

111700

Specimen Container Identifier

Identifier of container (box, block, microscope slide, etc.) for the specimen under observation.

111701

Processing type

Type of processing that tissue specimen underwent.

111702

DateTime of processing

Date and time of processing step.

111703

Processing step description

Description of the individual step in the tissue processing sequence.

111704

Sampling Method

Method of sampling used to derive specimen from its parent.

111705

Parent Specimen Identifier

Identifier of the parent specimen that gave rise to the current specimen.

111706

Issuer of Parent Specimen Identifier

Assigning authority for parent specimen's identifier.

111707

Parent specimen type

Parent specimen type that gave rise to current specimen.

111708

Position Frame of Reference

Description of coordinate system and origin reference point on parent specimen, or parent specimen container, or image used for localizing the sampling site or location within container or image.

111709

Location of sampling site

Reference to image of parent specimen localizing the sampling site; may include referenced Presentation State object.

111710

Location of sampling site X offset

Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference.

111711

Location of sampling site Y offset

Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference.

111712

Location of sampling site Z offset

Location of sampling site of specimen (nominal center) relative to the Position Frame of Reference.

111718

Location of Specimen

Description of specimen location, either in absolute terms or relative to the Position Frame of Reference.

111719

Location of Specimen X offset

Location of specimen (nominal center) relative to the Position Frame of Reference in the X dimension.

111720

Location of Specimen Y offset

Location of specimen (nominal center) relative to the Position Frame of Reference in the Y dimension.

111721

Location of Specimen Z offset

Location of specimen (nominal center) relative to the Position Frame of Reference in the Z dimension.

111723

Visual Marking of Specimen

Description of visual distinguishing identifiers. E.g., ink, or a particular shape of the specimen.

111724

Issuer of Specimen Identifier

Assigning authority for specimen identifier.

111726

Dissection with entire specimen submission

Dissection of specimen with submission of all its sections for further processing or examination.

111727

Dissection with representative sections submission

Dissection of specimen with submission of representative sections for further processing or examination.

111729

Specimen storage

A workflow step, during which tissue specimens are stored in a climate-controlled environment.

111741

Transmission illumination

Transmission illumination method for specimen microscopy.

111742

Reflection illumination

Reflection illumination method for specimen microscopy.

111743

Epifluorescence illumination

Epifluorescence illumination method for specimen microscopy.

111744

Brightfield illumination

Brightfield illumination method for specimen microscopy.

111745

Darkfield illumination

Darkfield illumination method for specimen microscopy.

111746

Oblique illumination

Oblique illumination method for specimen microscopy.

111747

Phase contrast illumination

Phase contrast illumination method for specimen microscopy.

111748

Differential interference contrast

Differential interference contrast method for specimen microscopy.

111749

Total internal reflection fluorescence

Total internal reflection fluorescence method for specimen microscopy.

111750

Ultrasound Contact

A method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires applanation of the cornea.

111751

Ultrasound Immersion

A method of obtaining ophthalmic axial measurements that uses ultrasound, and that requires immersion of the patient's eye in fluid as he lies in a supine position.

111752

Optical

A method of obtaining ophthalmic axial measurements that uses light.

111753

Manual Keratometry

Measurements taken of the corneal curvature using a manual keratometer.

111754

Auto Keratometry

Measurements taken of the corneal curvature using an automated keratometer.

111755

Simulated Keratometry

Simulated Keratometry measurements derived from corneal topography.

111756

Equivalent K-reading

Corneal power measurements using Scheimpflug camera.

111760

Haigis

The Haigis IOL calculation formula.

Haigis W, Lege B, Miller N, Schneider B. Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis. Graefes Arch Clin Exp Ophthalmol 2000;238:765-73.

111761

Haigis-L

The Haigis-L IOL calculation formula.

Haigis W. Intraocular lens calculation after refractive surgery for myopia: Haigis-L formula. J Cataract Refract Surg. 2008 Oct;34(10):1658-63.

111762

Holladay 1

The Holladay 1 IOL calculation formula.

Holladay JT, Prager TC, Chandler TY, Musgrove KH, Lewis JW, Ruiz RS. A three-part system for refining intraocular lens power calculations. J Cataract Refract Surg. 1988; 14:17-24.

111763

Holladay 2

The Holladay 2 IOL calculation formula.

111764

Hoffer Q

The Hoffer Q IOL calculation formula. Hoffer KJ. The Hoffer Q formula: a comparison of theoretic and regression formulas. J Cataract Refract Surg 1993;19:700-12. Errata. J Cataract Refract Surg 1994;20:677 and 2007;33:2-3.

111765

Olsen

The Olsen IOL calculation formula. Olsen T. Calculation of intraocular lens power: a review. Acta Ophthalmol. Scand. 2007: 85: 472-485.

111766

SRKII

The SRKII IOL calculation formula. Sanders DR, Retzlaff J, Kraff MC. Comparison of the SRK II formula and other second generation formulas. J Cataract Refract Surg. 1988 Mar;14(2):136-41.

111767

SRK-T

The SRK-T IOL calculation formula.

Retzlaff JA, Sanders DR, Kraff MC. Development of the SRK/T intraocular lens implant power calculation formula. J Cataract Refract Surg 1990;16:333-40. Erratum 1990;16:528.

111768

ACD Constant

The "ACD Constant" used in IOL calculation.

111769

Haigis a0

The "Haigis a0" constant used in IOL calculation.

111770

Haigis a1

The "Haigis a1" constant used in IOL calculation.

111771

Haigis a2

The "Haigis a2" constant used in IOL calculation.

111772

Hoffer pACD Constant

The "Hoffer pACD Constant" used in IOL calculation.

111773

Surgeon Factor

The "Surgeon Factor" constant used in IOL calculation.

111776

Front Of Cornea To Front Of Lens

Anterior chamber depth defined as the front of the cornea to the front of the lens.

111777

Back Of Cornea To Front Of Lens

Anterior chamber depth defined as the back of the cornea to the front of the lens.

111778

Single or Anterior Lens

Refers to the anterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens.

111779

Posterior Lens

Refers to the posterior lens when there are two lenses in the eye. The distance, in mm, from the anterior surface of the lens to the posterior surface of the lens.

111780

Measurement From This Device

Value obtained from measurements taken by the device creating this SOP Instance.

111781

External Data Source

Value obtained by data transfer from an external source - not from measurements taken by the device providing the value.

111782

Axial Measurements SOP Instance

Axial Measurements DICOM SOP Instance.

111783

Refractive Measurements SOP Instance

Refractive Measurements DICOM SOP Instance.

111786

Standard Deviation of measurements used

Standard Deviation is a simple measure of the variability of a data set.

111787

Signal to Noise Ratio

Signal to Noise Ratio of the data samples taken to create a measurement.

111800

Visual Field 24-2 Test Pattern

Test pattern, nominally covering an area within 24° of fixation. Consists of 54 test points a minimum of 3° from each meridian and placed 6° apart.

The "-2" distinguishes this from another 24° pattern (no longer supported).

111801

Visual Field 10-2 Test Pattern

Test pattern, nominally covering an area within 10° of fixation. Consists of 68 test points a minimum of 1° from each meridian and placed 2° apart.

The "-2" in this case indicates its point layout to be similar to the 30-2 and 24-2.

111802

Visual Field 30-2 Test Pattern

Test pattern consisting of test point locations within 30° of fixation. Consists of 76 test points a minimum of 3° from each meridian and placed 6° apart.

The "-2" distinguishes this from another 30° pattern (no longer supported).

111803

Visual Field 60-4 Test Pattern

Test pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart.

The "-4" distinguishes this from a similar 60° pattern having 4 additional points.

111804

Visual Field Macula Test Pattern

Test pattern consisting of 16 test point locations within 10° of fixation a minimum of 1° from each meridian and placed 2° apart.

111805

Visual Field Central 40 Point Test Pattern

Test pattern consisting of 40 test point locations within 30° of fixation that spread out radially from fixation.

111806

Visual Field Central 76 Point Test Pattern

Test pattern consisting of 76 test point locations within 30° of fixation a minimum of 3° from each meridian and placed 6° apart.

111807

Visual Field Peripheral 60 Point Test Pattern

Test pattern consisting of 60 test point locations between 30° and 60° of fixation a minimum of 6° from each meridian and placed 12° apart.

111808

Visual Field Full Field 81 Point Test Pattern

Test pattern consisting of 81 test point locations within 60° of fixation that spread out radially from fixation.

111809

Visual Field Full Field 120 Point Test Pattern

Test pattern consisting of 120 test point locations within 60° of fixation that spread out radially from fixation, concentrated in the nasal hemisphere.

111810

Visual Field G Test Pattern

Test pattern for Glaucoma and general visual field assessment with 59 test locations of which 16 test locations are in the macular area (up to 10° eccentricity) and where the density of test location is reduced with eccentricity. The test can be extended with the inclusion of 14 test locations between 30° and 60° eccentricity, 6 of which are located at the nasal step.

111811

Visual Field M Test Pattern

Test pattern for the macular area. Orthogonal test pattern with 0.7° spacing within the central 4° of eccentricity and reduced density of test locations between 4 and 10, 5° of eccentricity. 81 test locations over all. The test can be extended to include the test locations of the Visual Field G Test Pattern between 10, 5° and 60°.

111812

Visual Field 07 Test Pattern

Full field test pattern with 48 test locations from 0-30° and 82 test locations from 30-70°. Reduced test point density with increased eccentricity. Can be combined with screening and threshold strategies.

111813

Visual Field LVC Test Pattern

Low Vision Central. Orthogonal off-center test pattern with 6° spacing. 75 test locations within the central 30°. Corresponds with the 32/30-2 excluding the 2 locations at the blind spot, including a macular test location. The LVC is linked with a staircase threshold strategy starting at 0 dB intensity and applies stimulus area V.

111814

Visual Field Central Test Pattern

General test corresponding to the 30-2 but excluding the 2 test locations in the blind spot area, hence with 74 instead of 76 test locations.

111815

Visual Field SITA-Standard Test Strategy

Swedish Interactive Thresholding Algorithm (SITA). Strategy gains testing efficiency through use of visual field and information theory models.

In: Bengtsson B, Olsson J, Heijl A, Rootzen H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmologica Scandinavica, 1997, 75: 368-375.

111816

Visual Field SITA-SWAP Test Strategy

Adaptation of SITA testing methods to Blue-Yellow testing.

111817

Visual Field SITA-Fast Test Strategy

Similar to SITA-Standard but with less strict criteria for closing test points. Intended for patients who must be tested in the shortest possible time.

In: Bengtsson B, Hejl A. SITA Fast, a new rapid perimetric threshold test. Description of methods and evaluation in patients with manifest and suspect glaucoma. Acta Ophthalmologica Scandinavica, 1998, 76: 431-437.

111818

Visual Field Full Threshold Test Strategy

Threshold test algorithm that determines a patient's sensitivity at each test point in the threshold test pattern by adjusting intensity by 4 dB steps until the patient changes their response, and then adjusts the intensity in the opposite direction by 2 dB steps until the patient changes their response again. The last stimulus seen by the patient is recognized as the threshold for that point.

The starting values are determined by first thresholding a "primary" point in each quadrant then using the results of each primary point to determine the starting values for neighboring points.

111819

Visual Field FastPac Test Strategy

Similar to the Full Threshold algorithm except that it steps by 3 dB and only crosses the threshold only once.

In: Flanagan JG, Wild JM, Trope GE. Evaluation of FASTPAC, a new strategy for threshold estimation with the Humphrey Field Analyzer, in a glaucomatous population. Ophthalmology, 1993, 100: 949-954.

111820

Visual Field Full From Prior Test Strategy

Identical to Full Threshold except that starting values are determined by the results of a previous test performed using the same test pattern and the Full Threshold test strategy.

111821

Visual Field Optima Test Strategy

Similar to FastPac except that the steps are pseudo-dynamic (differ based on the intensity of the last presentation).

111822

Visual Field Two-Zone Test Strategy

Suprathreshold testing strategy, in which each point is initially tested using stimulus that is 6 dB brighter than the expected hill of vision. If the patient does not respond, the stimulus is presented a second time at the same brightness. If the patient sees either presentation, the point is marked as "seen"; otherwise it is marked as "not seen".

111823

Visual Field Three-Zone Test Strategy

An extension of the two-zone strategy in which test points where the second stimulus is not seen are presented with a third stimulus at maximum brightness.

111824

Visual Field Quantify-Defects Test Strategy

An extension of the two-zone strategy, in which test points where the second stimulus is not seen receive threshold testing to quantify the depth of any detected scotomas.

111825

Visual Field TOP Test Strategy

Tendency Oriented Perimetry. Fast thresholding algorithm. Test strategy makes use of the interaction between neighboring test locations to reduce the test time compared to normal full threshold strategy by 60-80%.

In: Morales J, Weitzman ML, Gonzalez de la Rosa M. Comparison between Tendency-Oriented Perimetry (TOP) and octopus threshold perimetry. Ophthalmology, 2000, 107: 134-142.

111826

Visual Field Dynamic Test Strategy

Dynamic strategy is a fast thresholding strategy reducing test duration by adapting the dB step sizes according to the frequency-of-seeing curve of the threshold. Reduction of test time compared to normal full threshold strategy 30-50%.

111827

Visual Field Normal Test Strategy

Traditional full threshold staircase strategy. Initial intensities are presented, based on anchor point sensitivities in each quadrant and based on already known neighboring sensitivities. In a first run, thresholds are changed in 4dB steps until the first response reversal. Then the threshold is changed in 2 dB steps until the second response reversal. The threshold is calculated as the average between the last seen and last not-seen stimulus, supposed to correspond with the 50% point in the frequency-of-seeing curve.

111828

Visual Field 1-LT Test Strategy

One level screening test: Each test location is tested with a single intensity. The result is shown as seen or not-seen. The intensity can either be a 0 dB stimulus or a predefined intensity.

111829

Visual Field 2-LT Test Strategy

Two level screening test: Each test location is initially tested 6 dB brighter than the age corrected normal value.

111830

Visual Field LVS Test Strategy

Low Vision Strategy is a full threshold normal strategy with the exception that it starts at 0 dB intensity and applies stimulus area V.

111831

Visual Field GATE Test Strategy

German Adaptive Threshold Estimation is a fast strategy based on a modified 4-2 staircase algorithm, using prior visual fields to calculate the starting intensity. In: Chiefer U, Pascual JP, Edmunds B, Feudner E, Hoffmann EM, Johnson CA, Lagreze WA, Pfeiffer N, Sample PA, Staubach F, Weleber RG, Vonthein R, Krapp E, Paetzold J. Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Investigative Ophthalmology and Visual Science, 2009, 51: 488-494.

111832

Visual Field GATEi Test Strategy

Similar to GATE. The i stands for initial. If there was no prior visual field test to calculate the starting values, an anchor point method is used to define the local start values.

111833

Visual Field 2LT-Dynamic Test Strategy

A test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the dynamic threshold strategy.

111834

Visual Field 2LT-Normal Test Strategy

A test started as two level screening test. In the course of the test, the threshold of relative defects and/or normal test locations has been quantified using the normal full threshold strategy.

111835

Visual Field Fast Threshold Test Strategy

Takes neighborhood test point results into account and offers stimuli with an adapted value to save time.

111836

Visual Field CLIP Test Strategy

Continuous Luminance Incremental Perimetry, which measures at first the individual reaction time of the patient and threshold values in every quadrant. The starting value for the main test is slightly below in individual threshold.

111837

Visual Field CLASS Strategy

A supra threshold screening strategy. The starting stimuli intensities depend on the classification of the patient's visual hill by measuring the central (fovea) or peripheral (15° meridian) threshold. The result of each dot slightly underestimates the sensitivity value (within 5 dB).

111838

Age corrected

Mode for determining the starting luminance for screening test points - the starting luminance s is chosen based on the age of the patient.

111839

Threshold related

Mode for determining the starting luminance for screening test points - the starting luminance is chosen based on the results of thresholding a set of "primary" test points (one in each quadrant).

111840

Single luminance

Mode for determining the starting luminance for screening test points - in this case, all starting luminance is set to the same value.

111841

Foveal sensitivity related

Mode for determining the starting luminance for screening test points - the starting luminance is chosen based on the result of the foveal threshold value.

111842

Related to non macular sensitivity

Mode for determining the starting luminance for screening test points - the starting luminance is chosen based on the result of four threshold values measured near the 15° meridian (one in each quadrant).

111843

Automated Optical

Real time evaluation of the camera image to recognize blinks and fixation losses with influence on the test procedure. Blinks that interfere with stimuli presentation cause the automated repetition of such stimulus presentations. Fixation losses can be used to delay the stimulus presentation until correct fixation is regained.

111844

Blind Spot Monitoring

A method of monitoring the patient's fixation by periodically presenting stimulus in a location on the background surface that corresponds to the patient's blind spot.

111845

Macular Fixation Testing

A method of monitoring the patient's fixation by presenting the stimulus to the patient's macula.

111846

Observation by Examiner

A method of monitoring the patient's fixation by observation from the examiner of the patient.

111847

Outside normal limits

Analysis Results are outside normal limits.

111848

Borderline

Analysis Results are borderline.

111849

Abnormally high sensitivity

Analysis Results identify abnormally high sensitivity.

111850

General reduction in sensitivity

Analysis Results identify general reduction in sensitivity.

111851

Borderline and general reduction in sensitivity

Analysis Results identify Borderline and general reduction in sensitivity.

111852

Visual Field Index

Index of a patient's remaining visual field normalized for both age and generalized defect.

111853

Visual Field Loss Due to Diffuse Defect

Estimate of the portion of a patient's visual field loss that is diffuse (i.e., spread evenly across all portions of the visual field).

111854

Visual Field Loss Due to Local Defect

Estimate of the portion of a patient's visual field loss that is local (i.e., not spread evenly across all portions of the visual field).

111855

Glaucoma Hemifield Test Analysis

An analysis of asymmetry between zones of the superior and inferior visual field. It is designed to be specific for defects due to glaucoma.

111856

Optical Fixation Measurements

The data output of an optical fixation monitoring process, consisting of a list of positive and negative numbers indicating the quality of patient fixation over the course of a visual field test. The value 0 represents the initial fixation. Negative numbers indicate a measuring error (i.e., the patient blinked). Positive numbers quantify the degree of eccentricity from initial fixation.

111900

Macula centered

An image of at least 15° angular subtend that is centered on the macula; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111901

Disc centered

An image of at least 15° angular subtend that is centered on the optic disc; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111902

Lesion centered

An image of any angular subtend that is centered on a lesion located in any region of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111903

Disc-macula centered

An image of at least 15° angular subtend centered midway between the disc and macula and containing at least a portion of the disc and both the disc and the macula; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111904

Mid-peripheral-superior

An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-temporal and superior-nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111905

Mid-peripheral-superior temporal

An image of at least 15° angular subtend positioned between the central zone and the equator in the superior-temporal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111906

Mid-peripheral-temporal

An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-temporal and inferior-temporal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111907

Mid-peripheral-inferior temporal

An image of at least 15° angular subtend positioned between the central zone and the equator in the inferior-temporal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111908

Mid-peripheral-inferior

An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the inferior-temporal and inferior-nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111909

Mid-peripheral-inferior nasal

An image of at least 15° angular subtend positioned between the central zone and the equator in the inferior-nasal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111910

Mid-peripheral-nasal

An image of at least 15° angular subtend positioned between the central zone and the equator, and spanning both the superior-nasal and inferior-nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111911

Mid-peripheral-superior nasal

An image of at least 15° angular subtend positioned between the central zone and the equator in the superior-nasal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111912

Peripheral-superior

An image of at least 15° angular subtend positioned between the equator and the ora serrata, and spanning both the superior temporal and superior nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111913

Peripheral-superior temporal

An image of at least 15° angular subtend positioned between the equator and ora serrata in the superior-temporal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111914

Peripheral-temporal

An image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the superior-temporal and inferior-temporal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111915

Peripheral-inferior temporal

An image of at least 15° angular subtend positioned between the equator and ora serrata in the inferior-temporal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111916

Peripheral-inferior

An image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the inferior-temporal and inferior-nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111917

Peripheral-inferior nasal

An image of at least 15° angular subtend positioned between the equator and ora serrata in the inferior-nasal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111918

Peripheral-nasal

An image of at least 15° angular subtend positioned between the equator and ora serrata, and spanning both the superior-nasal and inferior-nasal quadrants of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111919

Peripheral-superior nasal

An image of at least 15° angular subtend positioned between the equator and ora serrata in the superior-nasal quadrant of the fundus; see Section U.1.8 “Relative Image Position Definitions” in PS3.17 .

111920

Time domain

Identifies the use of physical signals with respect to time to capture information.

111921

Spectral domain

Identifies the use of physical signals with respect to multiple frequencies to capture information.

111922

No corneal compensation

No compensation algorithm for corneal birefringence.

111923

Corneal birefringence compensation

Algorithm to compensate for variability in corneal birefringence.

111924

Retinal topography

Measurement of the retinal surface contour relative to an assigned datum plane.

111925

Retinal nerve fiber layer thickness

Measurement approximating the distance related to the structure between the internal limiting membrane (ILM) and the outer boarder of the retinal nerve fiber layer (RNFL); see Section III.6 “Retinal Thickness Definition” in PS3.17 .

111926

Ganglion cell complex thickness

Measurement approximating the distance related to the structure between the ILM and the outer border of the inner plexiform layer (IPL), called the ganglion cell complex (GCC); see Section III.6 “Retinal Thickness Definition” in PS3.17 .

111927

Total retinal thickness (ILM to IS-OS)

Measurement approximating the distance related to the structure between the ILM and the inner-outer segment junction (IS-OS); see Section III.6 “Retinal Thickness Definition” in PS3.17 .

111928

Total retinal thickness (ILM to RPE)

Measurement approximating the distance related to the structure between the ILM and the retinal pigment epithelium (RPE); see Section III.6 “Retinal Thickness Definition” in PS3.17 .

111929

Total retinal thickness (ILM to BM)

Measurement approximating the distance related to the structure between the ILM and the Bruch's membrane (BM); see Section III.6 “Retinal Thickness Definition” in PS3.17 .

111930

Absolute ophthalmic thickness

Thickness of a component of the posterior segment of the eye. E.g., thickness of retina, choroid, etc.

111931

Thickness deviation category from normative data

Ophthalmic Thickness map based upon statistical significance category (such as percentile) from a normative data set.

111932

Thickness deviation from normative data

Ophthalmic Thickness map based upon deviation (such as microns) from a normative data set.

111933

Related ophthalmic thickness map

Ophthalmic Thickness Map related to another Ophthalmic Thickness Map or another SOP Instance.

111934

Disc-Fovea

An anatomic point centered midway between the disc and fovea centralis.

111935

p>5%

Assuming the null hypothesis is true, the conditional percent probability of observing this result is not statistically significant.

111936

p<5%

Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 95% unlikely to happen by chance.

111937

p<2%

Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 98% unlikely to happen by chance.

111938

p<1%

Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 99% unlikely to happen by chance.

111939

p<0.5%

Assuming the null hypothesis is true, the conditional percent probability of observing this result is statistically significant, 99.5% unlikely to happen by chance.

111940

Corneal axial power map

A two dimensional representation of the axial curvature of the cornea. Axial curvature is calculated from the reciprocal of the distance from a point on a meridian normal at the point to the corneal topographer axis. Also known as sagittal curvature.

111941

Corneal instantaneous power map

A two dimensional representation of the instantaneous curvature of the cornea. Instantaneous curvature is calculated from the reciprocal of the distance from a point on a meridian normal at the point to the center of curvature of that point. Also called tangential curvature.

111942

Corneal refractive power map

A two dimensional representation of the refractive power of the cornea. Corneal refractive power is calculated using Snell's Law.

111943

Corneal elevation map

A two dimensional representation of the elevation of the cornea. Elevation is calculated as the distance from a point on the corneal surface to a point on a reference surface along a line parallel to the corneal topographer axis. For the purpose of visualization the reference surface is usually a sphere or an ellipse.

111944

Corneal wavefront map

A two dimensional representation of a wavefront aberration surface of the cornea. Wavefront aberration surface is calculated from the corneal elevation data fit with either the Zernike polynomial series or the Fourier Series. Maps generally display total aberrations and selectable higher order aberrations.

111945

Elevation-based corneal tomographer

A device that measures corneal anterior surface shape using elevation-based methods (stereographic and light slit-based). Rasterstereography images a grid pattern illuminating the fluorescein dyed tear film with 2 cameras to produce 3D. Slit-based devices scan the cornea, usually by rotation about the instrument axis centered on the cornea vertex.

111946

Reflection-based corneal topographer

A reflection-based device that projects a pattern of light onto the cornea and an image of the reflection of that pattern from the tear film is recorded in one video frame. Light patterns include the circular mire pattern (Placido disc) and spot matrix patterns. Sequential scanning of light spots reflected from the corneal surface is also used requiring multiple video frames for recording.

111947

Interferometry-based corneal tomographer

An Interference-based device that projects a beam of light onto and through the cornea. Light reflected from within the cornea is combined with a reference beam giving rise to an interference pattern. Appropriately scanned, this imaging is used to construct 3-dimensional images of the cornea from anterior to posterior surfaces. E.g., swept source OCT.

112000

Chest CAD Report

A structured report containing the results of computer-aided detection or diagnosis applied to chest imaging and associated clinical information.

112001

Opacity

The shadow of an absorber that attenuates the X-Ray beam more effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly white (of lesser photometric density) than its surround [Fraser and Pare].

112002

Series Instance UID

A unique identifier for a series of DICOM SOP instances.

112003

Associated Chest Component

A named anatomic region within the chest cavity.

112004

Abnormal interstitial pattern

A collection of opacities detected within the continuum of loose connective tissue throughout the lung, that is not expected in a diagnostically normal radiograph.

112005

Radiographic anatomy

A type of anatomy that is expected to be detectable on a radiographic (X-Ray based) image.

112006

Distribution Descriptor

Characteristic of the extent of spreading of a finding or feature.

112007

Border definition

Characteristic of the clarity of the boundary or edges of a finding or feature.

112008

Site involvement

The part(s) of the anatomy affected or encompassed by a finding or feature.

112009

Type of Content

Characteristic of the matter or substance within a finding or feature.

112010

Texture Descriptor

Characteristic of the surface or consistency of a finding or feature.

112011

Positioner Primary Angle

Position of the X-Ray beam about the patient from the RAO to LAO direction where movement from RAO to vertical is positive.

112012

Positioner Secondary Angle

Position of the X-Ray beam about the patient from the caudal to cranial direction where movement from caudal to vertical is positive.

112013

Location in Chest

The zone, lobe or segment within the chest cavity in which a finding or feature is situated.

112014

Orientation Descriptor

Vertical refers to orientation parallel to the superior-inferior (cephalad-caudad) axis of the body, with horizontal being perpendicular to this, and an oblique orientation having projections in both the horizontal and vertical.

112015

Border shape

Characteristic of the shape formed by the boundary or edges of a finding or feature.

112016

Baseline Category

Indicates whether a finding was considered a target lesion, non-target lesion, or non-lesion during evaluation of a baseline series, according to a method such as RECIST.

112017

Cavity extent as percent of volume

The extent of a detected cavity, represented as the percent of the surrounding volume that it occupies.

112018

Calcification extent as percent of surface

The extent of a detected calcification, represented as the percent of the surrounding surface that it occupies.

112019

Calcification extent as percent of volume

The extent of a detected calcification, represented as the percent of the surrounding volume that it occupies.

112020

Response Evaluation

A heading for the reporting of response evaluation for treatment of solid tumors.

112021

Response Evaluation Method

The system applied in the reporting of response evaluation for treatment of solid tumors.

112022

RECIST

Response Evaluation Criteria In Solid Tumors; see Normative References.

112023

Composite Feature Modifier

A term that further specifies the name of an item that is an inferred correlation relating two or more individual findings or features.

112024

Single Image Finding Modifier

A term that further specifies the name of an item that was detected on one image.

112025

Size Descriptor

A qualitative descriptor for the extent of a finding or feature.

112026

Width Descriptor

A qualitative descriptor for the thickness of tubular structures, such as blood vessels.

112027

Opacity Descriptor

A characteristic that further describes the nature of an opacity.

112028

Abnormal Distribution of Anatomic Structure

The type of adverse affect that a finding or feature is having on the surrounding anatomy.

112029

WHO

Response evaluation method as defined in chapter 5, "Reporting of Response" of the WHO Handbook for Reporting Results for Cancer Treatment; see Normative References.

112030

Calcification Descriptor

Identification of the morphology of detected calcifications.

112031

Attenuation Coefficient

A quantitative numerical statement of the relative attenuation of the X-Ray beam at a specified point. Usually expressed in Hounsfield units [referred to as CT Number in Fraser and Pare].

112032

Threshold Attenuation Coefficient

An X-Ray attenuation coefficient that is used as a threshold. E.g., in calcium scoring.

112033

Abnormal opacity

An opacity that is not expected in a diagnostically normal radiograph.

112034

Calculation Description

A textual description of the mathematical method of calculation that resulted in a calculated value.

112035

Performance of Pediatric and Adult Chest Radiography, ACR

American College of Radiology. ACR Standard for the Performance of Pediatric and Adult Chest Radiography. In: Standards. Reston, Va: 2001:95-98.

112036

ACR Position Statement

American College of Radiology. ACR Position Statement for Quality Control and Improvement, Safety, Infection Control, and Patient Concerns. In: Practice Guidelines and Technical Standards. Reston, Va: 2001:iv.

112037

Non-lesion Modifier

A descriptor for a non-lesion object finding or feature, used to indicate whether the object was detected as being internal or external to the patient's body.

112038

Osseous Modifier

A concept modifier for an Osseous Anatomy, or bone related, finding.

112039

Tracking Identifier

A text label used for tracking a finding or feature, potentially across multiple reporting objects, over time. This label shall be unique within the domain in which it is used.

112040

Tracking Unique Identifier

A unique identifier used for tracking a finding or feature, potentially across multiple reporting objects, over time.

112041

Target Lesion Complete Response

Disappearance of all target lesions.

112042

Target Lesion Partial Response

At least a 30% decrease in the sum of the Longest Diameter of target lesions, taking as reference the baseline sum Longest Diameter.

112043

Target Lesion Progressive Disease

At least a 20% increase in the sum of the Longest Diameter of target lesions, taking as reference the smallest sum Longest Diameter recorded since the treatment started, or the appearance of one or more new lesions.

112044

Target Lesion Stable Disease

Neither sufficient shrinkage to qualify for Partial Response nor sufficient increase to qualify for Progressive Disease, taking as reference the smallest sum Longest Diameter since the treatment started.

112045

Non-Target Lesion Complete Response

Disappearance of all non-target lesions and normalization of tumor marker level.

112046

Non-Target Lesion Incomplete Response or Stable Disease

Persistence of one or more non-target lesions and/or maintenance of tumor marker level above the normal limits.

112047

Non-Target Lesion Progressive Disease

Appearance of one or more new lesions and/or unequivocal progression of existing non-target lesions.

112048

Current Response

The current response evaluation for treatment of solid tumors, according to a method such as RECIST.

112049

Best Overall Response

Best response recorded from the start of the treatment until disease progression/recurrence, taking as reference for Progressive Disease the smallest measurements recorded since the treatment started, according to a method such as RECIST.

112050

Anatomic Identifier

A text identifier of an anatomic feature when a multiplicity of features of that type may be present, such as "Rib 1", "Rib 2" or thoracic vertebrae "T1" or "T2".

112051

Measurement of Response

A measured or calculated evaluation of response. E.g., according to a method such as RECIST, the value would be the calculated sum of the lengths of the longest axes of a set of target lesions.

112052

Bronchovascular

Of or relating to a bronchial (lung) specific channel for the conveyance of a body fluid.

112053

Osseous

Of, relating to, or composed of bone.

112054

Secondary pulmonary lobule

The smallest unit of lung surrounded by connective tissue septa; the unit of lung subtended by any bronchiole that gives off three to five terminal bronchioles [Fraser and Pare].

112055

Agatston scoring method

A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the maximum X-Ray attenuation coefficient and the area of calcium deposits.

112056

Volume scoring method

A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the volume of each calcification, typically expressed in mm3.

112057

Mass scoring method

A method of calculating an overall calcium score, reflecting the calcification of coronary arteries, based on the total mass of calcification, typically expressed in mg.

112058

Calcium score

A measure often arrived at through calculation of findings from CT examination, which is a common predictor of significant stenosis of the coronary arteries.

112059

Primary complex

The combination of a focus of pneumonia due to a primary infection with granulomas in the draining hilar or mediastinal lymph nodes [Fraser and Pare].

112060

Oligemia

General or local decrease in the apparent width of visible pulmonary vessels, suggesting less than normal blood flow (reduced blood flow) [Fraser and Pare].

112061

Abnormal lines (1D)

Linear opacity of very fine width, i.e., a nearly one dimensional opacity.

112062

Abnormal lucency

Area of abnormal very low X-Ray attenuation, typically lower than aerated lung when occurring in or projecting over lung, or lower than soft tissue when occurring in or projecting over soft tissue.

112063

Abnormal calcifications

A calcific opacity within the lung that may be organized, but does not display the trabecular organization of true bone [Fraser and Pare].

112064

Abnormal texture

Relatively homogeneous, extended, pattern of abnormal opacity in the lung, typically low in contrast.

112065

Reticulonodular pattern

A collection of innumerable small, linear, and nodular opacities that together produce a composite appearance resembling a net with small superimposed nodules. The reticular and nodular elements are dimensionally of similar magnitude [Fraser and Pare].

112066

Beaded septum sign

Irregular septal thickening that suggests the appearance of a row of beads; usually a sign of lymphangitic carcinomatosis, but may also occur rarely in sarcoidosis [Fraser and Pare].

112067

Nodular pattern

A collection of innumerable, small discrete opacities ranging in diameter from 2-10 mm, generally uniform in size and widespread in distribution, and without marginal spiculation [Fraser and Pare].

112068

Pseudoplaque

An irregular band of peripheral pulmonary opacity adjacent to visceral pleura that simulates the appearance of a pleural plaque and is formed by coalescence of small nodules [Fraser and Pare] .

112069

Signet-ring sign

A ring of opacities (usually representing a dilated, thick-walled bronchus) in association with a smaller, round, soft tissue opacity (the adjacent pulmonary artery) suggesting a "signet ring" [Fraser and Pare].

112070

Air bronchiologram

Equivalent of air bronchogram, but in airways assumed to be bronchioles because of peripheral location and diameter [Fraser and Pare].

112071

Air bronchogram

Radiographic shadow of an air-containing bronchus; presumed to represent an air-containing segment of the bronchial tree (identity often inferred) [Fraser and Pare].

112072

Air crescent

Air in a crescentic shape in a nodule or mass, in which the air separates the outer wall of the lesion from an inner sequestrum, which most commonly is a fungus ball of Aspergillusspecies [Fraser and Pare].

112073

Halo sign

Ground-glass opacity surrounding the circumference of a nodule or mass. May be a sign of invasive aspergillosis or hemorrhage of various causes [Fraser and Pare].

112074

Target Lesion at Baseline

Flag denoting that this lesion was identified, at baseline, as a target lesion intended for tracking over time [RECIST].

112075

Non-Target Lesion at Baseline

Flag denoting that this lesion was not identified, at baseline, as a target lesion, and was not intended for tracking over time [RECIST].

112076

Non-Lesion at Baseline

Flag denoting that this finding was identified, at baseline, as a category other than a lesion, and was not intended for tracking over time [RECIST].

112077

Vasoconstriction

Local or general reduction in the caliber of visible pulmonary vessels, presumed to result from decreased flow occasioned by contraction of muscular pulmonary arteries [Fraser and Pare].

112078

Vasodilation

Local or general increase in the width of visible pulmonary vessels resulting from increased pulmonary blood flow [Fraser and Pare].

112079

Architectural distortion

A manifestation of lung disease in which bronchi, pulmonary vessels, a fissure or fissures, or septa of secondary pulmonary lobules are abnormally displaced [Fraser and Pare].

112080

Mosaic perfusion

A patchwork of regions of varied attenuation, interpreted as secondary to regional differences in perfusion [Fraser and Pare].

112081

Pleonemia

Increased blood flow to the lungs or a portion thereof, manifested by a general or local increase in the width of visible pulmonary vessels [Fraser and Pare].

112082

Interface

The common boundary between the shadows of two juxtaposed structures or tissues of different texture or opacity (edge, border) [Fraser and Pare].

112083

Line

A longitudinal opacity no greater than 2 mm in width [Fraser and Pare].

112084

Lucency

The shadow of an absorber that attenuates the primary X-Ray beam less effectively than do surrounding absorbers. In a radiograph, any circumscribed area that appears more nearly black (of greater photometric density) than its surround [Fraser and Pare].

112085

Midlung window

A midlung region, characterized by the absence of large blood vessels and by a paucity of small blood vessels, that corresponds to the minor fissure and adjacent peripheral lung [Fraser and Pare].

112086

Carina angle

The angle formed by the right and left main bronchi at the tracheal bifurcation [Fraser and Pare].

112087

Centrilobular structures

The pulmonary artery and its immediate branches in a secondary lobule; HRCT depicts these vessels in certain cases; a.k.a. core structures or lobular core structures [Fraser and Pare].

112088

Anterior junction line

A vertically oriented linear or curvilinear opacity approximately 1-2 mm wide, commonly projected on the tracheal air shadow [Fraser and Pare].

112089

Posterior junction line

A vertically oriented, linear or curvilinear opacity approximately 2 mm wide, commonly projected on the tracheal air shadow, and usually slightly concave to the right [Fraser and Pare].

112090

Azygoesophageal recess interface

A space in the right side of the mediastinum into which the medial edge of the right lower lobe extends [Fraser and Pare].

112091

Paraspinal line

A vertically oriented interface usually seen in a frontal chest radiograph to the left of the thoracic vertebral column [Fraser and Pare].

112092

Posterior tracheal stripe

A vertically oriented linear opacity ranging in width from 2-5 mm, extending from the thoracic inlet to the bifurcation of the trachea, and visible only on lateral radiographs of the chest [Fraser and Pare].

112093

Right tracheal stripe

A vertically oriented linear opacity approximately 2-3 mm wide extending from the thoracic inlet to the right tracheobronchial angle [Fraser and Pare].

112094

Stripe

A longitudinal composite opacity measuring 2-5 mm in width; acceptable when limited to anatomic structures within the mediastinum [Fraser and Pare].

112095

Hiatus

A gap or passage through an anatomical part or organ; especially : a gap through which another part or organ passes.

112096

Rib Scalene Tubercle

A small rounded elevation or eminence on the first rib for the attachment of the scalenus anterior.

112097

Vertebral Intervertebral Notch

A groove that serves for the transmission of the vertebral artery.

112098

Subscapular Fossa

The concave depression of the anterior surface of the scapula.

112099

Scapular Spine

A sloping ridge dividing the dorsal surface of the scapula into the supraspinatous fossa (above), and the infraspinatous fossa (below).

112100

Scapular Supraspinatus Fossa

The portion of the dorsal surface of the scapula above the scapular spine.

112101

Scapular Infraspinatus Fossa

The portion of the dorsal surface of the scapula below the scapular spine.

112102

Aortic knob

The portion of the aortic arch that defines the transition between its ascending and descending limbs.